Stockwinners Market Radar for February 14, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
PI | Hot Stocks20:17 EST Impinj CEO sells $1.87M in common stock - In a regulatory filing, Impinj disclosed that its CEO Chris Diorio sold 15K shares of common stock on February 10th in a total transaction size of $1.87M.
|
COIN | Hot Stocks20:05 EST Cathie Wood's ARK Investment bought 14.6K shares of Coinbase today
|
JOBY | Hot Stocks20:04 EST Cathie Wood's ARK Investment bought 14.8K shares of Joby Aviation today
|
PATH | Hot Stocks20:03 EST Cathie Wood's ARK Investment bought 13.7K shares of UiPath today
|
CRDO | Hot Stocks19:16 EST Credo Technology sees Q4 revenue at $30M-$32M, consensus $55.1M - In a regulatory 8-K filing, the company states: "Credo Technology Group Holding Ltd's ("Credo's") largest customer has reduced its demand forecast for certain Credo products for reasons Credo understands are unrelated to Credo's performance. Credo does not expect its market share with the customer will be affected. As a result of this reduction and macroeconomic headwinds, Credo now expects fiscal fourth quarter revenue, ending April 29, 2023, in the range of $30 million to $32 million. Also, Credo expects revenue for the full fiscal year ending April 27, 2024 will be flat compared to the full fiscal year ending April 29, 2023. From a projected low point in Q4 FY23 or Q1 FY24, Credo expects to see sequential growth during FY24. Credo's long-term financial model remains unchanged. In addition, Credo is managing its operating expenses to support future revenue growth and profitability. Credo believes fundamental technology trends in its industry remain consistent, with Credo's customers and ecosystem partners continuing to require increasing bandwidth, power efficiency and collaborative problem solving to meet their expected connectivity needs. Based on Credo's customer and partner engagements, Credo remains enthusiastic about the prospects and growth opportunities for its connectivity solutions."
|
PET | Hot Stocks18:55 EST Wag! Group director buys $2.62M in common stock - In a regulatory filing, Wag! Group disclosed that its director Brian Yee bought 992K shares of common stock on February 10th in a total transaction size of $2.62M.
|
AIG... | Hot Stocks18:21 EST Third Point buys AIG, exits T-Mobile in Q4 - Third Point disclosed in an SEC filing its holdings as of December 31, 2022. The fund's six new buys during the fourth quarter included, by size of position, AIG (AIG), Microsoft (MSFT), International Flavors & Fragrances (IFF), Fidelity National Information Services (FIS), and LabCorp (LH). Third Point exited 21 holdings during the quarter, including by size of previous position EQT Corp. (EQT), Range Resources (RRC), T-Mobile (TMUS), Cano Health (CANO), and CSX (CSX). The fund increased its stake in four holdings, including by size of previous position Bath & Body Works (BBWI), TJX (TJX), DuPont (DD), and iShares 1-3 Year Treasury Bond ETF (SHY). Third Point reduced its stake in four holdings, including by size of previous position Ventyx Bio (VTYX), Disney (DIS), and PG&E (PCG). The fund's top holdings as of December 31, in order of size, were PG&E, Colgate-Palmolive (CL), Danaher (DHR), Bath & Body Works, and UnitedHealth (UNH).
|
LEE | Hot Stocks18:17 EST Lee Enterprises receives Nasdaq notification over Form 10-Q - Lee Enterprises has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that, as a result of the company's continued delay in filing its Annual Report on Form 10-K for the fiscal year ended September 25, 2022 and because the company did not file its Quarterly Report on Form 10-Q for the period ended December 25, 2022, within the prescribed time period, the company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1).
|
SCAQ | Hot Stocks18:05 EST Stratim Cloud Acquisition Corp trading resumes
|
KVSA | Hot Stocks17:55 EST Khosla Ventures Acquisition Corp trading resumes
|
SCAQ | Hot Stocks17:41 EST Stratim Cloud Acquisition signs LOI to acquire Force Pressure Control - Stratim Cloud Acquisition announced the signing of a binding letter-of-intent, or LOI, for a business combination with the identified target, Force Pressure Control. Force provides pressure control related rental tools and services required during frac and flowback well operations. The company designs and assembles proprietary equipment that provides superior solutions for its clients and yields high margins, free cash flows and returns on invested capital. Force's proprietary equipment is used in oil and natural gas production, as well as in geothermal "clean energy" applications. Under the terms of the LOI, SCAC would acquire 100% of the equity interests of Force from its existing equity holders in exchange for 12M shares of SCAC Class A Common Stock, $120M in cash or notes, and includes an earnout of up to 3M additional shares of SCAC Class A Common Stock based on the combined company's 2023 EBITDA exceeding levels specified in the Term Sheet. SCAC intends to announce additional details regarding the proposed business combination upon execution of a definitive purchase agreement. The business combination agreement is expected to be completed by the end of the first quarter of 2023. Completion of a business combination is subject to, among other matters, the completion of due diligence, no material adverse change, the negotiation of a definitive agreement providing for the transaction, satisfaction of the conditions negotiated therein and approval of the transaction by the SCAC and Force boards and the stockholders of SCAC. The parties have agreed to mutual exclusivity until March 14. However, there can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated on the terms or timeframe currently contemplated, or at all.
|
VAPO | Hot Stocks17:35 EST Vapotherm CEO buys $500K in common stock - In a regulatory filing, Vapotherm disclosed that its CEO Joseph Army bought 476K shares of common stock on February 10th in a total transaction size of $500K.
|
ADI | Hot Stocks17:34 EST Analog Devices raises quarterly dividend 13% to 86c per share - Analog Devices announced that its Board of Directors has voted to increase its quarterly dividend from 76c per outstanding share of common stock to 86c, which represents an increase of 13% and is the equivalent of $3.44 annually. "Our highly profitable business model has proven resilient throughout dynamic macro environments, generating positive free cash flow for 26 consecutive years," said Vincent Roche, CEO and Chair. "We target returning 100% of free cash flow to shareholders through both dividend payments and share repurchases, and we have returned more than $12 billion to shareholders in the last five years. Over the long-term, we are committed to reinvesting in our business, while delivering significant value to shareholders." The increase is effective with the dividend payable on March 8, 2023, to shareholders of record as of the close of business on February 27, 2023.
|
GOOG GOOGL | Hot Stocks17:33 EST Google rolls out Privacy Sandbox for Android in Beta - Anthony Chavez, VP, of Privacy Sandbox at Google blogged in part, on the company's Keyword earlier: "...Last year, we announced the Privacy Sandbox on Android, an industry-wide initiative to raise the bar for user privacy and ensure continued access to free content and services. Building on our web efforts, we're developing solutions for digital advertising that limit user data sharing and don't rely on cross-app identifiers...Today, we're entering the next phase of this initiative, rolling out the first Beta for the Privacy Sandbox on Android to eligible devices. With the Beta, users and developers will be able to experience and evaluate these new solutions in the real world...The Privacy Sandbox for Android Beta will roll out gradually, starting with a small percentage of Android 13 devices, and will expand over time. If your device is selected for the Beta, you'll receive an Android notification letting you know. The Privacy Sandbox Beta provides new APIs that are designed with privacy at the core, and don't use identifiers that can track your activity across apps and websites. Apps that choose to participate in the Beta can use these APIs to show you relevant ads and measure their effectiveness...You'll be able to control your Beta participation by going to the Privacy Sandbox section of Settings." Reference Link
|
DIS... | Hot Stocks17:28 EST Nelson Peltz's Trian buys Disney, cuts Sysco in Q4 - Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of December 31, 2022. The fund's one new buy during the fourth quarter was Disney (DIS). Trian exited its position in one holding, P&G (PG), increased its stake in one holding, General Electric (GE), and reduced its stake in one holding, Sysco (SYY). The fund's top holdings as of December 31, in order of size, were Invesco (IVZ), Disney, Janus Henderson (JHG), Wendy's (WEN), and GE.
|
APA... | Hot Stocks17:26 EST Paulson exits positions in APA Corp., VMWare, Barrick Gold - John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of December 31, 2022. Paulson exited seven holdings during the quarter, including by size of previous position, APA Corp. (APA), VMWare (VMW), Barrick Gold (GOLD), and Rumble (RUM). Paulson reduced its stake in seven holdings, including by size of previous position, Horizon Therapeutics (HZNP), SSR Mining (SSRM), Thryv Holdings (THRY), Overseas Shipholding (OSG), and Agnico Eagle Mines (AEM). The fund's top holdings as of December 31, 2022, in order of size, were Brightsphere Investment (BSIG), Horizon Therapeutics, Bausch Health (BHC), Novagold Resources (NG) and AngloGold Ashanti (AU).
|
BAESY | Hot Stocks17:24 EST BAE Systems awarded $466.41M Army contract modification - BAE Systems was awarded a $466.41M modification to a contract for M109A7 Self-Propelled Howitzers and M992A3 Carrier, Ammunition, Tracked vehicles; Total Package Fielding support hardware kits, and support. Work has an estimated completion date of December 30, 2026. FY22 weapons and tracked combat vehicle procurement, Army funds in the amount of $83.26M were obligated at the time of the award. U.S. Army Contracting Command, Detroit Arsenal, Michigan, is the contracting activity.
|
TRIP | Hot Stocks17:23 EST TripAdvisor sees FY23 adjusted EBITDA margin flat year-over-year - Sees FY23 revenue growth that reflects diverse growth profiles across portfolio and is consistent with broader travel growth trends. "In 2023, our focus will be on both growing our restaurant base and our diner base," the company said in earnings call prepared remarks. "For restaurateurs, we believe we are providing more value with products such as TheFork Pay, and testing different pricing options. For diners, we remain focused on driving awareness and user experience through our app. Importantly, in 2023 we expect to see significant improvements in profitability, driven by fixed and discretionary cost leverage and an increase in media efficiency."
|
TRIP | Hot Stocks17:18 EST TripAdvisor jumps 7% to $27.05 after Q4 results beat estimates
|
META | Hot Stocks17:16 EST Instagram is ending live shopping on March 16 to focus on other 'features' - In a comment on its support page, Instagram noted: " Beginning on March 16, you will no longer be able to tag products in live broadcasts on Instagram. This change will help us focus on products and features that provide the most value to our users. You will still be able to set up and run your shop on Instagram as we continue to invest in shopping experiences for people and businesses across feed, stories, Reels, ads and more." Reference Link
|
GPI | Hot Stocks17:15 EST Group 1 Automotive announces increase in 2023 dividend rate - Group 1 Automotive announced its board of directors has approved an increase in the 2023 annual dividend rate to $1.80 per share. This increase represents a 20%, or 30c, increase over 2022's annual dividend of $1.50 per share. Consistent with this increase, the board of directors declared a 45c dividend per share that will be payable on March 15 to stockholders of record as of March 1. "We are pleased to provide a 20% increase in our annual dividend rate as our strong cash flow continues to enable the Company to reward shareholders. Our top capital allocation priorities continue to be growing our business while also returning capital to our shareholders," said Daryl Kenningham, Group 1's president and CEO.
|
ABST | Hot Stocks17:15 EST Absolute Software Corp trading resumes
|
VTLE | Hot Stocks17:09 EST Vital Energy announces $127.6M Midland Basin acquisition - Vital Energy "announced the signing of a definitive purchase and sale agreement to acquire the assets of Driftwood Energy Operating, LLC, inclusive of all leasehold interests and hedges, in exchange for 1,578,948 shares of Vital common stock and $127.6 million of cash. The transaction is expected to close early April 2023 with an effective date of January 1, 2023, subject to customary closing conditions."
|
O | Hot Stocks17:05 EST Realty Income raises quarterly dividend to 25.45c from 24.85c per share - The dividend is payable on March 15, 2023, to stockholders of record as of March 1, 2023, and represents a 3.2% increase over the year-ago period.
|
WAFD | Hot Stocks17:01 EST Washington Federal raises quarterly dividend to 25c per share - The board of directors of Washington Federal, parent company of Washington Federal Bank, announced a regular quarterly cash dividend of 25c per share. The dividend will be paid March 10, 2023, to common shareholders of record as of February 24, 2023. This will be Washington Federal's 160th consecutive quarterly cash dividend.
|
KVSA | Hot Stocks16:59 EST Khosla Ventures Acquisition Corp trading halted, news pending
|
SCAQ | Hot Stocks16:56 EST Stratim Cloud Acquisition Corp trading halted, news pending
|
MCRI | Hot Stocks16:53 EST Monarch Casino says benefitting from enhanced Black Hawk property - John Farahi, co-chairman and CEO of Monarch, commented: "Monarch ended a strong 2022 with record fourth quarter and fiscal year financial results. We continue to benefit from the ongoing ramp up of our expanded and enhanced Black Hawk property. Net revenue and Adjusted EBITDA growth of over 20% in 2022 drove free cash flow to a record high, positioning Monarch to return capital to stockholders in the form of the one-time cash dividend and the recurring annual cash dividend to be paid quarterly, which we announced last week. As of now, we have approximately $30 million cash in the bank. We expect to pay the one-time dividend with the available cash, including additional cash generated from operations, with the remaining balance to be drawn from the new credit facility. Our strong balance sheet and free cash flow allows us to continue to invest in our existing operations, while we pursue potential M&A opportunities.
|
NBIX | Hot Stocks16:52 EST Neurocrine extends research collaboration with Sentia Medical Sciences - Sentia Medical Sciences announced that they have extended a research collaboration with Neurocrine aimed at discovering novel, long-acting corticotropin-releasing factor, or CRF, receptor antagonist peptide therapeutics. The collaboration will continue to leverage Sentia's proprietary peptide-based platform and Neurocrine's drug development expertise in CRF biology to develop and commercialize medicines with the potential to treat a variety of hypothalamic-pituitary-adrenal, or HPA, axis modulated diseases. Under the terms of the research collaboration extension, Sentia and Neurocrine will continue to work together to discover novel peptide antagonists targeting CRF and advance them to development candidate stage, after which Neurocrine would be solely responsible for all further development, manufacturing, regulatory and commercial activities. As part of the collaboration, Sentia will continue to receive committed research funding from Neurocrine to support discovery efforts. Sentia is eligible to receive milestone and royalty payments based on products developed from this collaboration.
|
THC... | Hot Stocks16:49 EST Greenlight buys Tenet, exits Intel in Q4 - David Einhorn's Greenlight Capital disclosed in an SEC filing its holdings as of December 31, 2022. The fund's four new buys during the fourth quarter included, by size of position, Tenet (THC), Gulfport Energy (GPOR), Funko (FNKO), and Coya Therapeutics (COYA). Greenlight exited five holdings during the quarter, including by size of previous position Intel (INTC), News Corp. Class B (NWS), and Rivian (RIVN). The fund increased its stake in ten holdings, including by size of previous position Kyndryl (KD), Teck Resources (TECK), Global Payments (GPN), Southwestern Energy (SWN), and Civitas (CIVI). Greenlight reduced its stake in 11 holdings, including by size of previous position Resideo (REZI), Victoria's Secret (VSCO), SPDR Gold Shares (GLD), GoPro (GPRO), and CNX Resources (CNX). The fund's top holdings as of December 31, in order of size, were Green Brick (GRBK), Brighthouse Financial (BHF), Consol Energy (CEIX), Kyndryl, and Teck Resources.
|
ACOR | Hot Stocks16:47 EST Acorda Therapeutics gets Nasdaq extension to meet minimum price requirements - The company states: "Acorda Therapeutics announced that the Nasdaq Hearings Panel has granted the Company's extension request until June 20, 2023 to regain compliance with the Nasdaq's minimum $1 bid price per share requirement. If at any time before June 20, 2023 the bid price of Acorda's stock closes at or above $1 per share for a minimum of 10 consecutive trading days, the Company will regain compliance with the Nasdaq Listing Rules. In the event that the Company cannot regain compliance organically during the extension period, the Company has committed to effecting a reverse stock split, which was authorized by shareholders in November 2022."
|
PRST | Hot Stocks16:47 EST Presto Automation sees FY23 ARR $28M-$30M - Reported Q2 ARR $29M, a decrease of 4% year-over-year. ARR would have been $32M but for the accounting treatment related to a specific customer contract that precluded the recognition of certain revenues related to the contract.
|
KNTE | Hot Stocks16:46 EST Kinnate Biopharma granted fast track designation for KIN-3248 from FDA - Kinnate Biopharma announced that the FDA has granted Fast Track designation for Kinnate's investigational pan-FGFR inhibitor, KIN-3248, for the treatment of patients with unresectable, locally advanced or metastatic cholangiocarcinoma, or CCA, harboring fibroblast growth factor receptor 2 gene fusions or other alterations, who have received at least one prior systemic therapy.
|
UPST | Hot Stocks16:44 EST Upstart falls 6% to $15.78 after Q4 results, below-consensus Q1 guidance
|
CLW | Hot Stocks16:43 EST Clearwater Paper sees FY23 CapEx $70M-$80M - Sees FY23 depreciation and amortization expense $98M-$101M. Sees FY23 interest expense $27M-$29M.
|
DVN | Hot Stocks16:43 EST Devon Energy increases fixed dividend 11% - As part of the fourth-quarter dividend announcement, the board approved an increase in the fixed dividend of 11%, or 2c per share. After the fixed dividend is funded, up to 50% of the excess free cash flow each quarter will be distributed to shareholders through the variable dividend.
|
ABNB | Hot Stocks16:42 EST Airbnb 'expects to maintain' FY23 EBITDA margins - The company states: "For the full year 2023, we expect to maintain the strong Adjusted EBITDA margin we delivered in 2022, as we offset the headwinds from lower ADR with incremental variable cost efficiencies and fixed cost discipline. In Q1 2023, we expect Adjusted EBITDA margin to be slightly down on a year-over-year basis due to changes in the timing of our brand marketing spend. Compared to Q1 2022, we expect sales and marketing in Q1 2023 will be approximately 150 basis points higher as a percent of revenue, but flat as a percent of revenue for the full year."
|
CLW | Hot Stocks16:42 EST Clearwater Paper sees Q1 adjusted EBITDA $65M-$75M - Sees $42M benefit in Q1 due to no major maintenance outages and lower impact from operational issues. Sees previously announced price increases and mix largely offsetting cost inflation. Guidance taken from Q4 earnings presentation slides.
|
DVN | Hot Stocks16:41 EST Devon Energy sees FY23 total oil equivalent production 643-663 mboepd
|
DVN | Hot Stocks16:40 EST Devon Energy sees Q1 total oil equivalent production 625-645 mboepd
|
IEP... | Hot Stocks16:36 EST Icahn boosts stake in Crown Holdings, reduces stake in Cheniere Energy - Carl Icahn's Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2022. Icahn increased its stake in three holdings, including by size of previous position, Icahn Enterprises (IEP) and Crown Holdings (CCK). Icahn reduced its stake in two holdings, including by size of previous position, Cheniere Energy (LNG) and Herc Holdings (HRI). Icahn's top holdings as of December 31, 2022, in order of size, were Icahn Enterprises, CVR Energy (CVI), FirstEnergy (FE), Xerox (XRX) and Herc Holdings.
|
VORB | Hot Stocks16:35 EST Virgin Orbit provides update on U.K. mission anomaly - Virgin Orbit said: "On 9 January 2023, during the first attempted orbital launch from the United Kingdom, Virgin Orbit's LauncherOne experienced an anomaly, leading to a premature shutdown of the rocket and failure to reach orbit. Virgin Orbit began its investigation into the failure within hours of the conclusion of the mission, under the leadership of distinguished aerospace veteran Jim Sponnick and Virgin Orbit Chief Engineer Chad Foerster. The failure investigation team received immediate access to extensive telemetry data collected during the mission from the ground stations in the UK, Ireland, and Spain, as well as systems onboard its carrier aircraft, providing a robust dataset that the investigation team has thoroughly examined. The investigation includes oversight by U.S. Federal Aviation Administration and the UK Air Accidents Investigation Branch (acting as the Space Accident Investigation Authority (SAIA) for the United Kingdom) and also participation by personnel from the Department of Defense, National Transportation Safety Board, and the National Reconnaissance Office. The U.K. Civil Aviation Authority will also be involved in investigation process. The investigation has confirmed that the Virgin Orbit team successfully executed pre-flight preparations, carrier aircraft takeoff, captive carry flight, and rocket release. The ignition, first stage flight, stage separation, second stage ignition, and fairing deployment of the LauncherOne rocket were nominal. Each of these milestones constituted a first-of-its-kind achievement for any orbital launch attempt from western Europe. LauncherOne performed successfully on all four prior operational flights, accurately delivering 33 payloads to their required orbits. The investigation team is utilizing a comprehensive fault tree, a very detailed timeline, and several other products to conduct the investigation in a rigorous manner. Key observations at this point in the investigation: The data is indicating that from the beginning of the second stage first burn, a fuel filter within the fuel feedline had been dislodged from its normal position; Additional data shows that the fuel pump that is downstream of the filter operated at a degraded efficiency level, resulting in the Newton 4 engine being starved for fuel. Performing in this anomalous manner resulted in the engine operating at a significantly higher than rated engine temperature; Components downstream and in the vicinity of the abnormally hot engine eventually malfunctioned, causing the second stage thrust to terminate prematurely; The early thrust termination ended the mission, and the second stage and its payloads fell back to Earth, landing in the approved safety corridor in the Atlantic Ocean. The investigation is employing a detailed action plan to develop key analyses and tests to replicate flight conditions and to aid in determining the root cause or causes of the failure. All potentially credible scenarios, including the one described above are being investigated. Numerous tests are underway to support the investigation and help lead to definitive conclusions. Ultimately, all credible causes of the failure will be addressed prior to the next LauncherOne mission.
|
UPST | Hot Stocks16:35 EST Upstart Holdings trading resumes
|
CF BP | Hot Stocks16:34 EST CF Industries enters into pact with BP for supply of 2.2 BCF of certified natgas - As part of its commitment to reduce its scope 3 emissions by 10% by 2030 and to reduce the lifecycle carbon intensity of ammonia production, CF Industries Holdings, Inc. (CF) announced that it has entered into an agreement with BP (BP) for the supply of 2.2B cubic feet of certified natural gas in 2023. MiQ-certified natural gas, or certified gas, is produced by companies whose operations are independently verified by a third-party auditor. These third parties provide a factual assessment of methane emissions intensity - the ratio of methane emissions to natural gas produced. CF Industries uses natural gas as a feedstock in the production of ammonia. Methane emissions throughout the natural gas supply chain are a significant contributor to the lifecycle carbon intensity of ammonia production and one of the two largest sources of scope 3 emissions for the Company.
|
ABST | Hot Stocks16:33 EST Absolute Software Corp trading halted, news pending
|
HYG... | Hot Stocks16:32 EST Elliott buys NiSource, cuts Aerojet in Q4 - Paul Singer's Elliott Management disclosed in an SEC filing its holdings as of December 31, 2022. The fund's six new buys during the fourth quarter included, by size of positoin, iShares iBoxx High Yield Corporate Bond ETF (HYG), SPDR Bloomberg High Yield Bond ETF (JNK), Liberty Broadband Class C (LBRDK), NiSource (NI), and News Corp (NWSA). Elliott increased its stake in three holdings during the quarter, including by size of previous position Pinterest (PINS), Triple Flag Precious Metals (TFPM), and E2open (ETWO). The fund reduced its stake in five holdings, including Aerojet (AJRD), Uniti Group (UNIT), Peabody Energy (BTU), Polestar Automotive (PSNY), and Howmet (HWM). Elliott's top holdings as of December 31, in order of size, were Triple Flag, Howmet, Marathon Petroleum (MPC), Pinterest, and Peabody Energy.
|
TTC | Hot Stocks16:31 EST Toro Company's Renee Peterson to retire as CFO, continue to serve as VP - The Toro Company announced that Renee J. Peterson, vice president and CFO, plans to retire in July 2023. Angela C. Drake, who currently serves as TTC's vice president, finance will succeed Peterson as vice president and chief financial officer, effective March 10, 2023. Peterson will continue to serve the organization as vice president, finance to assist with the transition in the coming months and provide ongoing leadership for key enterprise and finance initiatives."
|
GDDY | Hot Stocks16:29 EST GoDaddy sees FY23 CapEx about $50M
|
GDDY | Hot Stocks16:28 EST GoDaddy announces restructuring plan, reduction in force - On February 8, GoDaddy announced a restructuring plan aimed at driving over $100M in annualized cost savings through a reduction in force, operating expense reductions and integration of certain European brands and businesses within our Core Platform segment. GoDaddy expects restructuring and other related exit charges of approximately $55M-$65M to be recorded in the first half of 2023.
|
DIS... | Hot Stocks16:26 EST Appaloosa takes stake in Disney, exits position in Mosaic - David Tepper's Appaloosa Management disclosed in an SEC filing its holdings as of December 31, 2022. Appaloosa's three new buys during the fourth quarter included, by size of position, Disney (DIS), Caesars Entertainment (CZR), and Aptiv (APTV). Appaloosa exited one position during the quarter, Mosaic (MOS). Appaloosa increased its stake in seven holdings, including by size of previous position, HCA Healthcare (HCA), Chesapeake Energy (CHK), Salesforce (CRM), Uber Technologies (UBER), and Alibaba Group (BABA). Appaloosa reduced its stake in eight holdings, including by size of previous position, Meta Platforms (META), Constellation Energy (CEG), Enterprise Products Partners (EPD), and Sysco (SYY). Appaloosa's top holdings as of December 31, 2022, in order of size, were Constellation Energy, Alphabet (GOOG), Amazon (AMZN), Macy's (M), and Energy Transfer (ET).
|
LPX... | Hot Stocks16:21 EST Berkshire added more of top-holding Apple, Paramount in Q4 - Warren Buffett's Berkshire Hathaway disclosed in an SEC filing its holdings as of December 31, 2022. Berkshire increased three holdings in the quarter: buying 1.25M shares of Louisiana-Pacific (LPX), 2.42M shares of Paramount (PARA) and 338,888 shares of Apple (AAPL). The fund decreased eight holdings: selling 51.8M shares of TSMC (TSM), 71.1M shares of U.S. Bancorp (USB), 37.1M shares of BNY Mellon (BK), 7.42M shares of Activision Blizzard (ATVI) and 200,000 shares of Ally Financial (ALLY). Berkshire also reduced its stake in McKesson (MCK), Kroger (KR) and Chevron (CVX).The fund's top holdings as of December 31, 2022, in order of size, were Apple, Bank of America (BAC), Chevron, Coca-Cola (KO) and American Express (AXP).
|
SMWB | Hot Stocks16:21 EST Similarweb reports Q4 customer growth of 16 y/y to 4,049 - In Q4, the company: "Grew number of customers to 4,049 as of December 31, 2022, an increase of 16% compared to December 31, 2021. Grew average annual revenue per customer to approximately $51,600 in the fourth quarter of 2022, an increase of 8% compared to the fourth quarter of 2021. Grew number of customers with ARR of $100,000 or more to 337 as of December 31, 2022, an increase of 24% compared to December 31, 2021. Customers with ARR of $100,000 or more contributed 55% of the total ARR as of December 31, 2022, compared to 51% as of December 31, 2021. Dollar-based net retention rate for customers with ARR of $100,000 or more was 120% in the fourth quarter of 2022 as compared to 125% in the fourth quarter of 2021."
|
VINP | Hot Stocks16:18 EST Vinci Partners announces R$60M share buyback plan - Vinci Partners announced that its board of directors approved a share buyback plan and a share repurchase plan to buy back up to R$60M of the company's outstanding Class A common shares across both plans. These plans are approved to replace the share buyback and repurchase plans approved by our board of directors on June 15, 2022, which are set to expire on the date that the R$60M buyback limit set thereunder is reached.
|
DAR | Hot Stocks16:16 EST Darling Ingredients announces agreement with Cattlemen's Heritage Beef Company - Darling Ingredients announced that it has entered into an agreement with Cattlemen's Heritage Beef Company to purchase the off-take from its planned 2,000-head per day beef-processing facility in Mills County, Iowa. Darling Ingredients also announced that it intends to expand its nearby Bellevue, Nebraska, rendering plant to increase receiving and processing capacity. Cattlemen's Heritage Beef Company aims to provide a market for cattle raised by smaller, independent cattle producers. It plans to break ground on its Mills County beef-processing plant in the spring of 2023, with the goal of starting operations before the end of 2024. The Mills County facility is expected to bring around 800 jobs to the area and has a projected economic gain for Iowa of up to $8B, over the next five years.
|
ABNB | Hot Stocks16:15 EST Airbnb reports Q4 free cash flow $455M, up 21% y/y
|
LVMUY | Hot Stocks16:12 EST Louis Vuitton confirms Pharrell Williams to become new Men's Creative Director - Louis Vuitton confirmed that Pharrell Williams will become its new Men's Creative Director, effective immediately. His first collection for Louis Vuitton will be revealed this June during the Men's Fashion Week in Paris, the company said in a statement. "I am glad to welcome Pharrell back home, after our collaborations in 2004 and 2008 for Louis Vuitton, as our new Men's Creative Director. His creative vision beyond fashion will undoubtedly lead Louis Vuitton towards a new and very exciting chapter." declares Pietro Beccari, Louis Vuitton's Chairman and CEO.
|
UPST | Hot Stocks16:12 EST Upstart resume trading at 4:35 pm E.T. - Quotation in Upstart will resume at 4:30 pm E.T., according to Nasdaq. Shares have been halted ahead of the company's Q4 earnings and guidance.
|
HLF | Hot Stocks16:11 EST Herbalife Nutrition not providing FY23 guidance - Given the rapidly shifting macroeconomic sentiment and backdrop, as well as increased volatility in the market, the Company is not providing FY 2023 guidance. The Company will periodically reassess its ability to provide guidance when we believe future performance can be reasonably estimated.
|
ABNB | Hot Stocks16:09 EST Airbnb jumps 9% to $131.74 after Q4 earnings beat
|
QGEN | Hot Stocks16:09 EST Qiagen's TB blood test gains CE-marking under new EU IVDR framework - Qiagen announced the certification of QuantiFERON-TB Gold Plus - a tuberculosis blood test - under the European Union's 2017/746 In Vitro Diagnostic Medical Devices Regulation which is replacing the 98/79/EC In Vitro Diagnostic Directive. QFT-Plus is QIAGEN's trusted test, endorsed by the WHO, that aids in indirect detection of the bacteria that causes tuberculosis. The IVDR certification of QFT-Plus follows the QIAGEN ipsogen JAK2 RGQ PCR Kit as well as the NeuMoDx Systems and reagents, which gained IVDR CE-marking in late 2022. The updated set of rules, which became effective May 26, 2022, is now imposing higher and broader requirements on IVD manufacturers to receive CE-marking for their products. It also includes stronger oversight by independent EU-designated organizations, referred to as Notified Bodies. QuantiFERON-TB Gold Plus is classified as a Class C device under IVDR. With its more stringent mandates, the European regulatory framework comes closer to the FDA IVD regulations in the US and aims to ensure higher quality of health services for patients.
|
BYD | Hot Stocks16:08 EST Boyd Gaming raises quarterly dividend to 16c from 15c per share - The dividend is payable April 15, 2023, to shareholders of record at the close of business on March 15, 2023.
|
ELMD | Hot Stocks16:08 EST Electromed CEO Kathleen Skarvan to retire - Electromed announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around July 1, 2023. After her retirement she will serve as a non-employee member and chair of the company's board of directors. The Board of Directors is conducting a comprehensive search to identify a new President and CEO and engaged a national executive search firm to assist in the process. Skarvan has served as the company's Chief Executive Officer since 2012, joined the board of directors in 2013 and added the title of President in 2016. During her tenure leading the company, Skarvan has helped position Electromed as a leader in HFCWO airway clearance technology and has overseen a tripling of revenues and consistent profitability since 2015. Most recently, she implemented a multi-pronged strategic growth initiative that has resulted in a larger and more productive commercial team, increased market share and recently announced the limited market release of the fifth generation of innovation in airway clearance, the SmartVest Clearway. "It has been a privilege to lead Electromed for over ten years, and with the Company well positioned for continued success, I believe now is the right time to begin the transition to the next generation of leadership," stated Skarvan. "I look forward to continuing to work with the Board and management team over the coming months to identify an exemplary leader for our business and to ensure a successful transition."
|
ABNB | Hot Stocks16:07 EST Airbnb reports Q4 adjusted EBITDA $506M vs. $3333M y/y - The company states: "Guest demand remained strong throughout 2022. All regions saw significant growth in 2022 as guests increasingly crossed borders and returned to cities on Airbnb. Supply growth was also strong in 2022. We ended the year with 6.6 million global active listings, which is over 900,000 more listings than we had in the beginning of the year, excluding China. This growth was driven by our global network, where demand drives supply, as well as product innovations that continue to attract new Hosts. Looking forward to 2023, we're seeing strong demand in Q1, indicating that consumer confidence to travel remains high. "
|
UPST | Hot Stocks16:00 EST Upstart Holdings trading halted, news pending
|
GEN... | Hot Stocks15:36 EST Starboard buys Salesforce, exits Huntsman in Q4 - Jeffrey Smith's Starboard Value disclosed in an SEC filing its holdings as of December 31, 2022. The fund's six new buys during the fourth quarter included, by size of position, Salesforce (CRM), Vertiv (VRT), Splunk (SPLK), Acacia Research (ACTG), and iShares Russell Mid-Cap ETF (IWR). Starboard exited 35 positions during the quarter, including by size of previous position Huntsman (HUN), ACI Worldwide (ACIW), eHealth (EHTH), Digital Health Acquisition (DHAC), and Mount Rainier Acquisition (RNER). The fund increased its stake in three holdings, including by size of previous position GoDaddy (GDDY), iShares Russell 2000 Value ETF (IWD), and iShares Russell 2000 ETF (IWM). Starboard reduced its stake in eight holdings, including by size of previous position Commvault (CVLT), On Semiconductor (ON), Humana (HUM), Wix.com (WIX), and Pediatrix Medical (MD). The fund's top holdings as of December 31, in order of size, were GoDaddy, Aecom (ACM), Willis Towers Watson (WLTW), Gen Digital (GEN), and Salesforce.
|
JPM | Hot Stocks14:17 EST JPMorgan CFO sees Q1 banking revenue to be down about 20% - While speaking at the Credit Suisse Financial Services Forum, JPMorgan CFO Jeremy Barnum said: "So as of right now, remembering that last year's first quarter was particularly strong, we're expecting banking revenue to be down about 20% this quarter. So we'll see how it goes, but that's what it looks like to us right now. On the market side, last year's first quarter was also exceptionally strong. So we would be thrilled if we could duplicate last year's first quarter performance. And the quarter is starting out relatively strong. But as we sit here today, our central case is to probably come in a little bit worse than last year. But obviously, we're not even halfway through the quarter yet, so a lot of uncertainty out there and mostly how it goes."
|
JPM | Hot Stocks14:13 EST JPMorgan CFO says guidance now looks 'little bit more on conservative side' - Asked while speaking at the Credit Suisse Financial Services Forum about guidance given on JPMorgan's January earnings call, JPMorgan CFO Jeremy Barnum said: "So just starting with sort of the answer that I think everyone cares about first, we're not going to revise guidance today... I think the level of uncertainty is quite elevated right now. So a lot of what we talked about at earnings was really sort of emphasizing the unique moment that we're in and the amount of uncertainty that there is around how all these dynamics are going to play out. So the guidance that we gave at the time didn't feel particularly conservative to us and felt appropriate in light of the various factors in play. Since then, the way things have played out across a range of different dimensions, probably if pushed, I would have to say that the current guidance is a little bit more maybe on the conservative side relative to what we were at earnings. But we think that's appropriate conservatism because as much as there are some indicators that might lead you to think things would be a little better, there are other indicators that are reminding us of the uncertainty, it could easily make things be less good. So for now, no change in guidance, and the emphasis is really on the uncertainty given all the moving parts that are in dynamic right now."
|
FOX FOXA | Hot Stocks13:56 EST Fox Sports says Super Bowl LVII was most-streamed Super Bowl in history - Fox Sports said yesterday that the Super Bowl LVII broadcast drew a preliminary average audience of 113M viewers on Sunday across television and digital. Kansas City's victory delivered the best Super Bowl audience in six years ranking as the most-watched Super Bowl since 2017 on Fox, per Nielsen Media Research Fast National data and Adobe Analytics. 182.6M viewers watched all or part of Super Bowl LVII on Fox and Fox Deportes. Fox added that its average audience represents the second most-watched non-overtime Super Bowl on record and the second most-watched program in Fox Sports history. Super Bowl LVII was the most-streamed Super Bowl in history, delivering an average of 7M streams, up +18% over last year and up +103% over Fox's last Super Bowl stream in 2020, according to Adobe Analytics and traditional counting of streaming, which does not take into account co-viewing from connected devices. The Super Bowl LVII live streaming audience includes consumption across: com; the Fox Sports app; Fox.com; the FOX NOW app; NFL digital properties including the NFL mobile app, the NFL Fantasy mobile app, NFL.com, the NFL connected TV app and NFL+ for subscribers. Reference Link
|
LIXT | Hot Stocks13:52 EST Lixte Biotechnology reports publication of pre-clinical research on LB-100 - Lixte Biotechnology announced that, as recently reported in The Journal of Clinical Investigation, PP2A, the pharmacologic target of Lixte's lead clinical compound, LB-100, when deficient, enhances the effects of immune checkpoint blockade of cancer in a mouse model by a previously unappreciated mechanism. The article, entitled "PP2Ac/STRN4 negatively regulates STING-Type I interferon signaling in tumor associated macrophages," was recently published and is available online. The authors state that "PP2A/STRN4-YAP/TAZ is a previously unappreciated mechanism that mediate immunosuppression in tumor-associated macrophages and targeting PP2A/STRN4-YAP/TAZ axis can sensitize tumors to immunotherapy." John Kovach, M.D., CEO and Founder of Lixte, said, "This paper lends additional support to the potential immunotherapy application of LB-100 in cancer treatment. Dr. Winson S. Ho, Assistant Professor of Neurological Surgery at the UCSF School of Medicine, co-lead author of the article, and a former member of the LIXTE Board of Directors, bolsters the case for testing LB-100 in combination with immunotherapy in the clinic. Studies in animals show that low doses of LB-100 enhance the effectiveness of immunotherapy against a variety of cancer types by several mechanisms." Reference Link
|
KALA | Hot Stocks13:16 EST Kala recruiting for study of KPI-012 in participants with PCED - According to a post to the ClinicalTrials.gov website first posted on February 14, Kala Pharmaceuticals is recruiting for a Phase 2 study of participants diagnosed with persistent corneal epithelial defect, or PCED, at multiple U.S. centers to assess the safety and efficacy of KPI-012, a topical mesenchymal stem cell secretome therapy. After an initial cohort of at least 2 participants to evaluate the safety of the high strength product, participants in the second cohort will be randomized to treatment with either the product or vehicle for 8 weeks. The percentage of healing will be compared between groups treated with product and vehicle. The total length of study participation will be approximately 34 weeks, according to the post. Reference Link
|
AVYA | Hot Stocks12:49 EST Avaya: Vendors, suppliers to be paid in full - Avaya said it has filed a number of customary motions with the court to support its operations during the court-supervised process, including the continued payment of employee wages and benefits without interruption. Pursuant to the terms of the Financial Restructuring, all of the Company's vendors and suppliers will be paid in full, regardless of when goods or services were delivered. Vendors and suppliers to Avaya's non-U.S. subsidiaries will continue to be paid in the ordinary course.
|
AVYA RNG | Hot Stocks12:49 EST Avaya announces expansion of global partnership with RingCentral - Avaya (AVYA) announced today that it has extended and expanded its global, strategic partnership with RingCentral (RNG), which was formed in 2019 to introduce and launch Avaya Cloud Office by RingCentral. Avaya will continue to act as the exclusive sales agent for direct and partner sales of Avaya Cloud Office, Avaya's exclusive multi-tenanted cloud PBX solution, in the geographies where it is available. The partnership has also expanded to include additional go-to-market constructs that enable Avaya to sell Avaya Cloud Office to its installed base on a direct basis. In addition, Avaya will be compensated in cash as Avaya Cloud Office seats are sold and, in connection with the Financial Restructuring, RingCentral's preferred stock in Avaya will be eliminated.
|
AVYA APO | Hot Stocks12:48 EST Avaya initiates prepackaged financial restructuring via Chapter 11 - Avaya (AVYA) announced that it has entered into a Restructuring Support Agreement with overwhelming support of more than 90% of the Company's secured lenders. Implementing the Financial Restructuring will accelerate Avaya's ongoing business transformation, significantly enhance its ability to invest in its innovative cloud-based communications portfolio and position the Company for long-term success, it said in a statement. Completing the Financial Restructuring will reduce the Company's total debt by more than 75%, from approximately $3.4 billion today to approximately $800 million. Additionally, it will substantially increase Avaya's cash and strengthen its liquidity position, resulting in an expected emergence balance sheet with less than 1x net leverage. Due to the overwhelming support of its financial stakeholders, the Company expects to implement the Financial Restructuring on an expedited basis and complete this comprehensive balance sheet de-leveraging within 60 to 90 days. These actions will not impact the Company's customers, channel and strategic partners, suppliers, vendors or employees. To efficiently implement the Financial Restructuring, Avaya and all of its U.S. subsidiaries today filed voluntary prepackaged Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. During this process, Avaya will continue serving its customers and partners without interruption and providing them with outstanding communications solutions, service and support as usual. The Company has received commitments for $628 million in debtor-in-possession financing, including a $500 million new-money term loan from the Investor Group led by Apollo Global Management (APO) and Brigade Capital Management, LP, among others, and a $128 million ABL facility from a bank syndicate led by Citi. Upon Avaya's emergence from the court-supervised process, the $500 million new-money term loan and $128 million ABL facility will roll into exit facilities. Additionally, as part of the Financial Restructuring, certain members of the Investor Group have committed to provide $150 million of additional new-money financing through a fully backstopped debt rights offering at exit. This new committed financing of approximately $780 million, together with cash on hand and cash generated from ongoing operations, is expected to provide substantial liquidity to support Avaya during the restructuring process and beyond.
|
MSGS... | Hot Stocks12:48 EST Tiger Global boosts stakes in Visa, Mastercard, reduces position in Microsoft - Chase Coleman's Tiger Global disclosed in an SEC filing its holdings as of December 31. 2022. Tiger Global's 13 new buys during the fourth quarter included, by size of position, Madison Square Garden (MSGS), UnitedHealth (UNH), Yext (YEXT), Pinterest (PINS), and Delta (DAL). Tiger Global exited five positions during the quarter, including by size of previous position, Blackstone (BX), Qualcomm (QCOM), and European Wax Center (EWCZ). Tiger Global increased its stake in 11 holdings, including by size of previous position, Visa (V), Mastercard (MA), Dollar General (DG), AutoZone (AZO), and Workday (WDAY). Tiger Global reduced its stake in one holding, Microsoft (MSFT). Tiger Global's top holdings as of December 31. 2022, in order of size, were Microsoft, AutoZone, Workday, Madison Square Garden, and Visa.
|
AVYA | Hot Stocks12:46 EST Avaya initiates expedited, prepackaged financial restructuring via Chapter 11
|
AVYA RNG | Hot Stocks12:46 EST Avaya extends, expands strategic partnership with RingCentral
|
AVYA | Hot Stocks12:46 EST Avaya agreement to eliminate more than 75% of debt
|
AVYA | Hot Stocks12:45 EST Avaya takes action to acclerate transformation, fortify capital structure
|
AMD... | Hot Stocks12:42 EST Lone Pine exited PayPal, initiated AMD position during Q4 - Stephen Mandel's Lone Pine Capital disclosed in an SEC filing its holdings as of December 31, 2022. Lone Pine made seven new buys during the quarter, including, by size of position, AMD (AMD), Moderna (MRNA), ASML (ASML), Floor & Decor (FND) and Salesforce (CRM). Lone Pine exited seven positions during the quarter, including by size of previous position, PayPal (PYPL), Autodesk (ADSK), Meta Platforms (META), EQT Corporation (EQT) and Chesapeake (CHK). Lone Pine increased its stake in nine holdings, including Microsoft (MSFT), TSMC (TSM), TransDigm (TDG), UnitedHealth (UNH) and First Citizens (FCNCA). Lone Pine reduced its stake in seven holdings, including by size of previous position, Epam Systems (EPAM), Thermo Fisher (TMO), Cheniere Energy (LNG), Workday (WDAY) and Booking Holdings (BKNG). Lone Pine's top holdings as of December 31, 2022, in order of size, were Bath & Body Works (BBWI), Microsoft, Amazon.com (AMZN), Workday and TSMC.
|
SEM | Hot Stocks12:05 EST Select Medical, AtlantiCare enter JV for Southeastern New Jersey - Select Medical announced a joint venture agreement with AtlantiCare to own and manage operations of a new inpatient rehabilitation hospital and 13 outpatient physical therapy centers throughout the southeastern region of New Jersey. Select Medical will serve as both the majority owner and managing partner across the two post-acute care lines. Subject to state approvals, the construction of the new hospital in Galloway Township will begin this year. Under the agreement, Select Medical will contribute 13 outpatient physical therapy centers under its NovaCare Rehabilitation brand. All are currently operating in the southeastern region. Expected to open in 2024/2025, the new inpatient rehabilitation hospital will carry the Bacharach Institute for Rehabilitation name and serve patients recovering from debilitating illnesses and injuries including stroke and other neurological disorders, brain injury, spinal cord injury, amputation and other complex orthopedic conditions.
|
ANVS | Hot Stocks12:00 EST Annovis Bio falls -10.3% - Annovis Bio is down -10.3%, or -$2.04 to $17.80.
|
GEO | Hot Stocks12:00 EST Geo Group falls -14.3% - Geo Group is down -14.3%, or -$1.71 to $10.24.
|
DAVA | Hot Stocks12:00 EST Endava falls -15.1% - Endava is down -15.1%, or -$13.30 to $74.92.
|
NTB | Hot Stocks12:00 EST N.T. Butterfield rises 9.3% - N.T. Butterfield is up 9.3%, or $3.06 to $36.00.
|
PLTR | Hot Stocks12:00 EST Palantir rises 12.7% - Palantir is up 12.7%, or 97c to $8.58.
|
OCFT | Hot Stocks12:00 EST OneConnect rises 17.3% - OneConnect is up 17.3%, or $1.16 to $7.86.
|
PEG | Hot Stocks11:28 EST PSEG raises quarterly common stock dividend to 57c from 54c per share - The board of directors of Public Service Enterprise Group declared a 57c per share quarterly common stock dividend for the first quarter of 2023, payable on March 31 to shareholders of record on March 10. This action represents a 3c per share, or 5.6% increase, in the company's quarterly common stock dividend and brings the 2023 indicative annual rate to $2.28 per share.
|
CSX | Hot Stocks11:08 EST CSX reaches agreement with additional IAM, BRC divisions on paid sick leave - CSX announced that agreements have been secured with additional divisions of its International Association of Machinists and Aerospace Workers and Brotherhood of Railway Carmen unions on paid sick leave for railroad workers. The agreements were reached with the IAM Roadway Mechanics and the BRC Carmen for Fruit Growers Express Company. Both organizations represent employees who support CSX mechanical operations. CSX has been working collaboratively with its union partners, building momentum toward finding solutions that improve the work experience for its employees. The new agreements are the most recent of six paid sick leave agreements announced by CSX within the past week.
|
MYPS NCLH | Hot Stocks11:06 EST Norwegian Cruise Line relaunchs PLAYSTUDIOS' playAWARDS Program - PLAYSTUDIOS (MYPS) celebrates the relaunch of its partnership with Norwegian Cruise Line (NCLH). Players will have access to a robust offering of rewards from the famed international cruise line, including complimentary cruises, credits, and a myVIP group sailing in the Spring of 2023. The renewed partnership marks the end of a pause due to COVID and reintroduces the Norwegian brand to the playAWARDS platform for its 1.5 million daily average users, as well as more than 6 million monthly average users with $1M in new travel rewards. Additionally, 50 of the platform's most engaged players will be invited to a VIP sailing in April 2023.
|
TBLA | Hot Stocks11:03 EST Taboola announces Taboola Turnkey Commerce launch in partnership with TIME - Taboola announced Taboola Turnkey Commerce, a new turnkey offering that gives premium publishers the ability to create trustworthy content that attracts shoppers and helps them make great purchase decisions. This offering connects readers who trust publishers' editorial content with thoroughly tested and reviewed products and services. This offering creates a lucrative revenue source for publishers that capitalizes on readers with high purchase intent, while allowing retailers, financial services providers, and advertisers to reach buyers at massive scale, in trusted premium editorial environments. Taboola Turnkey Commerce launches with a new partnership between Taboola and TIME. Reaching a combined audience of 100 million globally across all platforms, TIME has chosen Taboola Turnkey Commerce to exclusively manage its new platform for product and services review-driven content.
|
X GM | Hot Stocks11:00 EST U.S. Steel enters supply agreement with General Motors - United States Steel Corporation (X) announced that it will supply General Motors (GM) with its advanced and sustainable steel solution called verdeX steel. The steel is manufactured with up to 75 percent fewer emissions compared to traditional blast furnace production, is made with up to 90 percent recycled content and is endlessly recyclable without degradation.
|
MVLA | Hot Stocks10:54 EST Pathfinder Acquisition Corp trading resumes
|
CLF | Hot Stocks10:53 EST Cleveland-Cliffs: 'Doomsday scenario' not materializing in steel
|
CLF | Hot Stocks10:53 EST Cleveland-Cliffs not idling any more steel assets
|
MVLA | Hot Stocks10:49 EST Pathfinder Acquisition Corp trading halted, volatility trading pause
|
GE... | Hot Stocks10:46 EST GE Aerospace announces firm order for 40 GEnx-1B, 20 GE9X engines from Air India - Air India, part of Tata Sons, has signed a firm order for 40 GEnx-1B and 20 GE9X engines, plus a multi-year TrueChoice engine services agreement, GE Aerospace (GE) announced. The deal was signed in coordination with the airline's firm order with Boeing (BA) for 20 Boeing 787 and 10 Boeing 777X aircraft, GE noted. "Air India also announced a CFM order for more than 800 LEAP engines, the largest LEAP order ever, to power its entire narrowbody purchase of 210 Airbus A320/A321neo aircraft and 190 Boeing 737 MAX-family aircraft. The announcement includes a multi-year CFM services agreement. CFM is a 50/50 joint business between GE and Safran Aircraft Engines," GE stated. "We are proud to continue our longstanding partnership with Tata Group and Air India. We look forward to working together to introduce these engines into Air India's fleet and are committed to ensuring they deliver exceptional performance," added H. Lawrence Culp, Jr., Chairman and CEO of GE and CEO of GE Aerospace.
|
FEDU | Hot Stocks10:41 EST Four Seasons Education (Cayman) Inc (ADR trading resumes
|
ACRGF CGC | Hot Stocks10:38 EST Acreage files proxy statement related to arrangement with Canopy Growth - Acreage Holdings (ACRGF) announced that it: (i) obtained an interim order of the Supreme Court of British Columbia dated January 18, 2023, as varied on February 13, 2023, in connection with its proposed arrangement involving Canopy Growth Corporation (CGC) and Canopy USA, LLC, to be implemented under a statutory plan of arrangement pursuant to section 288 of the Business Corporations Act; and (ii) filed its proxy statement and management information circular and related materials with the United States SEC in respect of the special meeting of holders of Acreage's Class D subordinate voting shares to be held on March 15 to approve the Floating Share Arrangement and matters related thereto. The special resolution approving the Floating Share Arrangement must be approved by: (i) at least 66 2/3% of the votes cast by Floating Shareholders, present virtually or represented by proxy and entitled to vote at the Meeting; and (ii) in accordance with Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions, a simple majority of votes cast by the Floating Shareholders, present virtually or represented by proxy and entitled to vote at the Meeting, excluding the votes in respect of Floating Shares cast by any "interested party", any "related party" of an "interested party" or any "joint actor." In addition to satisfying the conditions set forth in the Floating Share Arrangement Agreement, the implementation of the Floating Share Arrangement is subject to obtaining the final order of the Court, approval of the Floating Share Arrangement from Floating Shareholders at the Meeting and satisfaction of certain other conditions to implementing the Floating Share Arrangement, as set forth in the arrangement agreement dated October 24, 2022 among Acreage, Canopy and Canopy USA.
|
FEDU | Hot Stocks10:36 EST Four Seasons Education (Cayman) Inc (ADR trading halted, volatility trading pause
|
BA | Hot Stocks10:32 EST Boeing confirms Air India has selected up to 290 jets, including 737 MAX - Boeing and Air India confirmed the carrier has selected Boeing's family of airplanes to expand its future fleet with plans to invest in 190 737 MAX, 20 787 Dreamliner and 10 777X airplanes. The agreement between Boeing and Air India includes options for 50 additional 737 MAXs and 20 787-9s. When finalized, this will be the largest Boeing order in South Asia and a historic milestone in the aerospace company's nearly 90-year partnership with the carrier, Boeing said in a statement. "This acquisition of nearly 300, highly advanced Boeing jets is a core element of Vihaan.AI, the comprehensive transformation and growth strategy we are pursuing at Air India," said Campbell Wilson, CEO and MD, Air India. "These new airplanes will enable us to dramatically expand our network, both domestically and internationally, and will come with a completely new, world-class onboard product enabling passengers to travel in the highest levels of comfort and safety. With this order, we are delighted to take our long relationship with Boeing to a new level."
|
ECOR | Hot Stocks10:31 EST electroCore announces 1-for-15 reverse stock split - electroCore announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-15. The reverse stock split will take effect as of 12:01 a.m. ET, on Wednesday, February 15, 2023, and shares of electroCore will trade on a post-split basis on the Nasdaq Capital Market under the existing trading symbol, "ECOR," at the market open on February 15, 2023.
|
BA | Hot Stocks10:24 EST White House confirms Air India purchase of over 200 Boeing aircraft - The White House confirmed the purchase of over 200 Boeing aircraft by Air India and Boeing. "This purchase will support over one million American jobs across 44 states, and many will not require a four-year college degree," President Biden said in a statement. Shares of Boeing are up 2% to $219.50 following the news. Reference Link
|
FIS... | Hot Stocks10:19 EST JANA Partners takes stake in Fidelity National, exits stake in Momentive Global - JANA Partners disclosed in an SEC filing its holdings as of December 31, 2022. JANA's one new buy during the fourth quarter was Fidelity National Information Services (FIS). JANA exited one position during the quarter, Momentive Global (MNTV). JANA increased its stake in two holdings, including BlackSky Technology (BKSY). JANA reduced its stake in six holdings, including by size of previous position, New Relic (NEWR), Laboratory Corp. of America (LH), Mercury Systems (MRCY), and Freshpet (FRPT). JANA's top holdings as of December 31, 2022, in order of size, were TreeHouse Foods (THS). Freshpet, New Relic, Laboratory Corp. of America, and Fidelity National Information Services.
|
CLF | Hot Stocks10:07 EST Cleveland-Cliffs sees shipments rising to 4M ton level in Q1 - Comments taken from Q4 earnings conference call.
|
CLF | Hot Stocks10:07 EST Cleveland-Cliffs sees Q2 EBITDA 'significantly higher' than Q1
|
CLF | Hot Stocks10:06 EST Cleveland-Cliffs sees shipments rising to 4M ton level in Q1 - Comments taken from Q3 earnings conference call.
|
SFNC | Hot Stocks10:01 EST Simmons Bank appoints Richard Hughes as treasurer - Simmons Bank announced the addition of Richard Hughes as executive vice president and treasurer. Hughes will report to president and CFO Jay Brogdon and will be responsible for all Simmons Bank corporate treasury activities, including balance sheet management, investment portfolio, liquidity risk and funding, interest rate risk and capital planning. In addition, he will also have responsibility for financial planning and analysis, budgeting and forecasting. Prior to joining Simmons Bank, Hughes most recently served as executive vice president, Treasury Division, at BBVA USA.
|
BOXL | Hot Stocks10:00 EST Boxlight announces $15M share repurchase program - Boxlight announced that its Board of Directors approved a share repurchase program with authorization to repurchase up to $15M in shares of its Class A common stock.
|
MRC | Hot Stocks10:00 EST MRC Global falls -12.3% - MRC Global is down -12.3%, or -$1.65 to $11.74.
|
AIN | Hot Stocks10:00 EST Albany International falls -15.1% - Albany International is down -15.1%, or -$16.62 to $93.17.
|
DAVA | Hot Stocks10:00 EST Endava falls -15.2% - Endava is down -15.2%, or -$13.44 to $74.79.
|
BBAI | Hot Stocks10:00 EST BigBear.ai rises 6.9% - BigBear.ai is up 6.9%, or 27c to $4.19.
|
DDL | Hot Stocks10:00 EST Dingdong rises 9.4% - Dingdong is up 9.4%, or 46c to $5.35.
|
PLTR | Hot Stocks10:00 EST Palantir rises 10.8% - Palantir is up 10.8%, or 82c to $8.43.
|
BLDE | Hot Stocks09:54 EST Blade Air Mobility announces completion of electric aircraft test flight - Blade Air Mobility announced the successful completion of a test flight of BETA's ALIA-250 EVA at the Westchester County Airport in White Plains, New York. The flight marks the first test of a piloted electric vertical aircraft in the greater New York City, the company said in a statement. "During today's flight, the ALIA-250 flew alongside a conventional helicopter before pulling away for a second pass above the airport to highlight the dramatic noise reduction," it added. Shares of Blade Air Mobility are up 3% to $4.43 in morning trading.
|
AIN | Hot Stocks09:47 EST Albany International falls -8.9% - Albany International is down -8.9%, or -$9.77 to $100.02.
|
GEO | Hot Stocks09:47 EST Geo Group falls -10.7% - Geo Group is down -10.7%, or -$1.28 to $10.67.
|
DAVA | Hot Stocks09:47 EST Endava falls -12.7% - Endava is down -12.7%, or -$11.21 to $77.02.
|
SI | Hot Stocks09:47 EST Silvergate Capital rises 6.7% - Silvergate Capital is up 6.7%, or 98c to $15.69.
|
ZTS | Hot Stocks09:47 EST Zoetis rises 6.7% - Zoetis is up 6.7%, or $10.89 to $174.03.
|
PLTR | Hot Stocks09:47 EST Palantir rises 9.6% - Palantir is up 9.6%, or 73c to $8.34.
|
ESMT | Hot Stocks09:36 EST EngageSmart appoints Mark Daoust as CCO, Enterprise Solutions - EngageSmart has appointed Mark Daoust as Chief Customer Officer, Enterprise Solutions. In this role, Daoust will oversee Implementations, Onboarding, Pricing, Settlement Operations, Client Services, and Customer Success across EngageSmart's Enterprise solutions including InvoiceCloud, HealthPay24 and DonorDrive. He spent nearly 15 years at Hewlett-Packard Enterprise where he held a variety of leadership positions including as the Vice President of Operations and Services.
|
UL | Hot Stocks09:31 EST Yellow Wood Partners to acquire Unilever's Suave brand in North America - Yellow Wood Partners announced that it has signed a definitive agreement with Unilever to acquire its beauty and personal care brand, Suave, in North America. The transaction is anticipated to be completed in the second quarter of 2023.
|
DSX | Hot Stocks09:26 EST Diana Shipping to acquire m/v Nord Potomac for $27.9M - Diana Shipping announced that it has signed a Memorandum of Agreement to acquire from an unaffiliated third party the m/v Nord Potomac, a 2016 built Ultramax dry bulk vessel of 63,379 dwt, for a purchase price of $27.9M. The Company anticipates to take delivery of the vessel by the beginning of April 2023.
|
RMED | Hot Stocks09:22 EST Ra Medical Systems announces launch of LockeT device - Ra Medical Systems announced that its subsidiary, Catheter Precision has launched its LockeT product into the marketplace, with initial shipments to its distributors to begin immediately. LockeT can be used in conjunction with the closure of a percutaneous wound site, where a catheter has been placed through the skin into a blood vessel and then removed at the end of a procedure. The physician will suture the site and the vessel, and LockeT is used to hold the sutures in place. Locket can either complement or be used as an alternative to closure devices. Those devices include Perclose, sold by Abbott, Vascade, sold by Cardiva, a unit of Haemonetics, and Angioseal, sold by Terumo.
|
SINT | Hot Stocks09:18 EST Sintx announces Utah armor facility for advanced ceramics complete - SINTX Technologies announces that equipment installation along with key renovations and upgrades to its SINTX Armor facility in Salt Lake City are now complete. This milestone is the result of an intensive effort by the SINTX team to upgrade the facility's infrastructure and install armor manufacturing equipment that was acquired from Ohio-based B4C LLC. SINTX Armor is a 10,000 square-foot facility that can manufacture high-performance ceramic armor plates for personnel, aircraft, and vehicles. Products include 100% boron carbide or BoroShock, which is a high-strength material designed to protect special forces against high-velocity projectiles. Another product, DuraShockTM, is a composite of boron carbide and silicon carbide that is designed to protect law enforcement personnel. "SINTX Armor reiterates our commitment toward meeting the global demand for protective ceramic armor," said Dr. Sonny Bal, CEO of SINTX. "Our expertise in advanced ceramics has positioned us as a leader and innovator in the protective armor industry well into the future."
|
BZFD GNUS | Hot Stocks09:18 EST BuzzFeed enters exclusive content deal with Genius Brands' Frederator Network - Genius Brands International (GNUS), through its Frederator Network subsidiary, announced an exclusive content deal with BuzzFeed, a division of BuzzFeed (BZFD). The deal provides Genius Brands' Frederator Network the exclusive opportunity and first right to develop and produce longform series based on original digital properties created by the BuzzFeed Animation Lab. The first short-form content for series development by Frederator will be The Land of Boggs, a zany buddy comedy that currently boasts over10M followers. Other content under consideration for long-form development includes The Good Advice Cupcake, an aggressively optimistic pastry touting over 6M followers; the lowbrow sister comedy Weird Helga, with over 9M followers; and the adorable gender inclusive series, Chikn Nuggit, with over 7M followers. Frederator Studios will serve as the global content sales agent, headed by Director of Development Isabel Schultz, and Genius Brands' consumer products' division will develop the retail program for the slate of IP, spearheaded by Chief Brand Officer, Kerry Phelan, and in close partnership with BuzzFeed.
|
TTEK | Hot Stocks09:13 EST Tetra Tech selected for multiple A-E $200M services contracts in Korea - Tetra Tech announced that the U.S. Army Corps of Engineers, Far East District, selected Tetra Tech for a $200M, multiple-award contract to provide architect-engineer, A-E, services throughout the Republic of Korea. Under this five-year contract, Tetra Tech will provide A-E technical services in support of the U.S. Army, Air Force, and other federal agencies. Tetra Tech will conduct site investigations, prepare engineering design documents, and perform program management services to support the U.S. government's ongoing mission in the Pacific region. Tetra Tech will incorporate Leadership in Energy and Environmental Design, LEED, and other sustainability elements into the design of new and renovated buildings and infrastructure, including water, sanitation, and electrical utilities. "The U.S. Army Corps of Engineers has been a valued client for almost 50 years," said Dan Batrack, Tetra Tech Chairman and CEO. "We look forward to using our Leading with Science approach to support to the Far East District in its mission to deliver state-of-the-art engineering solutions on the Korean peninsula."
|
OPEN | Hot Stocks09:11 EST Opendoor Technologies announces inducement grants under Nasdaq listing rule - Opendoor Technologies announced that on February 8, 2023, the Compensation Committee of Opendoor's Board of Directors granted restricted stock units covering 1,941,692 shares of its common stock to fifteen non-executive employees, in connection with their commencement of employment, under the Opendoor Technologies Inc. 2022 Inducement Award Plan. The restricted stock units were granted as an inducement material to the employees' commencement of employment and were granted as an employment inducement award pursuant to Nasdaq Listing Rule 5635(c)(4).
|
SINT | Hot Stocks09:10 EST Sintx Technologies announces new Utah armor facility is fully operational - SINTX Technologies announced that equipment installation along with key renovations and upgrades to its SINTX Armor facility in Salt Lake City are now complete. This milestone is the result of an intensive effort by the SINTX team to upgrade the facility's infrastructure and install armor manufacturing equipment that was acquired from Ohio-based B4C LLC. "SINTX Armor reiterates our commitment toward meeting the global demand for protective ceramic armor," said Dr. Sonny Bal, CEO of SINTX. "Our expertise in advanced ceramics has positioned us as a leader and innovator in the protective armor industry well into the future."
|
NNDM | Hot Stocks09:09 EST Nano Dimension calls notice of special general meeting by Murchinson 'illegal' - Nano Dimension announced today the notice of special general meeting of the Company's shareholders issued by Murchinson on February 13th, 2023 failed to comply with core requirements under applicable law and thus was made without any underlying legal right to do so. Accordingly, the Illegal Notice will be disregarded by the Company. Shareholders are warned: Do not follow the instructions made in Bistricer's Murchinson's Illegal Notice. As previously announced on January 30th, 2023, the demand by Murchinson and Mark Bistricer to call a special shareholders meeting was rejected due to the failure of Murchison to comply with the requirements set forth under the Israeli Companies Law for calling such a meeting. Similarly, the Illegal Notice is not compliant with the Israeli Companies Law and should be disregarded by shareholders. Only The Company will inform its shareholders if and when a valid meeting will be held. Given the above, the Board of Directors of Nano Dimension is committed to carefully examine any demand made by shady Bistricer's Murchinson as well as their conduct surrounding the Company in order to protect the rights of all of Nano Dimension's shareholders and for the benefit of the Company. The Board is acting, and will continue to act, to upkeep the adequate corporate governance in the Company, in accordance with the applicable laws and regulations in Israel and the United States as well as with the Company's articles of association in order to protect the company and its shareholders' rights.
|
ARCW | Hot Stocks09:07 EST ARC Group agrees to acquire controlling profit-share interest in Luminous - ARC Group has entered into an agreement to acquire a controlling profit-sharing interest in US-based private equity and advisory firm Luminous Capital. The transaction enhances the global reach and service width for both ARC and Luminous. ARC Group's full-service financial platform is complemented by Luminous's private equity and advisory expertise through its deep-rooted knowledge of US capital markets with a focus on the rapidly growing legal cannabis industry. With Luminous launching its high yield private credit fund, this partnership will provide a unique opportunity for ARC's capital network to gain exposure to the fast growing, legal US cannabis industry. ARC Group President Sergio Camarero commented: "This is another key milestone in our growth strategy. Luminous Capital gives us a US presence in the financial hub of the world - New York City. We have worked with the Luminous team on their SPAC and observed the excellence and integrity their team brings to their advisory and investing practice. Luminous Capital is a step further in building out the ARC platform as we look to become an international financial institution strengthening the opportunities between Asia and the rest of the world."
|
WFC | Hot Stocks09:05 EST Wells Fargo CFO: Loan growth demand has moderated 'quite a bit'
|
WFC | Hot Stocks09:05 EST Wells Fargo comfortable with Q1, FY NII guidance, says CFO
|
WFC | Hot Stocks09:04 EST Wells Fargo has started repurchasing shares in Q1, says CFO - CFO Mike Santomassimo is speaking at the Credit Suisse 24th Annual Financial Services Forum.
|
CHH... | Hot Stocks09:04 EST Choice Hotels, Wells Fargo, MasterCard to launch new cobranded credit card - Choice Hotels (CHH) has finalized a multi-year agreement with Wells Fargo (WFC) and Mastercard (MA) to launch a new cobranded credit card program this spring. The new collaboration will make Wells Fargo the official issuer and Mastercard the exclusive payments network of credit cards through the award-winning Choice Privileges loyalty program. Aligning these companies make it possible to offer an exciting lineup of additional benefits and perks for Choice Privileges Mastercard cardmembers and make it even easier and faster to accrue points that can be redeemed for reward night stays at more than 7,500 hotels across more than 20 hotel brands including Cambria Hotels, Radisson Hotels, Radisson Blu, The Ascend Hotel Collection, Country Inn & Suites, Everhome, Comfort, and more.
|
CME BTC | Hot Stocks09:04 EST CME Group to launch event contracts on Bitcoin futures - CME Group (CME) will expand its suite of event contracts to include Bitcoin (BTC) futures on March 13, pending regulatory review.
|
EBAY | Hot Stocks09:02 EST eBay Motors announces launch of eBay Guaranteed Fit - eBay Motors announces the launch of eBay Guaranteed Fit, a program that gives users even more confidence when buying and selling on the marketplace. Shoppers can now look for the green 'Fits' compatibility checkmark on select parts and accessories listings to gauge whether the part will fit their vehicle. If the part arrives and doesn't fit as expected, eBay Motors will cover the cost of the return and the buyer will receive a full refund - enabling more seamless and trusted transactions for both shoppers and sellers.
|
RNA | Hot Stocks09:02 EST Avidity Biosciences' AOC 1020 granted Orphan Drug designation in FSHD - Avidity Biosciences announced that the FDA has granted Orphan Drug designation to AOC 1020 for the treatment of facioscapulohumeral muscular dystrophy - FSHD -, a serious, rare, hereditary muscle-weakening condition marked by life-long, progressive loss of muscle function that causes significant pain, fatigue, and disability. AOC 1020 is being evaluated in the Phase 1/2 FORTITUDE clinical trial in adults with FSHD and is the company's second muscle-targeting small interfering RNA AOC in clinical development. Avidity plans to share data from a preliminary assessment of AOC 1020 in approximately half of study participants from the FORTITUDE trial in the first half of 2024.
|
MAR | Hot Stocks08:57 EST Marriott: World Cup boosted Middle East RevPAR 44%
|
MAR | Hot Stocks08:52 EST Marriott: Capital returns to shareholders for 2023 could be $2.7B-$3.6B
|
ATHX | Hot Stocks08:52 EST Athersys granted clinical Type B meeting with FDA - Athersys announced that the company has been granted a clinical Type B meeting with the FDA. The company was previously granted Regenerative Medicine Advanced Therapy, or RMAT, and fast track designations for the use of MultiStem in the treatment of ischemic stroke. These designations enable sponsors to work closely with the FDA and receive its guidance on expediting advancement of designated programs. In the Type B meeting with the FDA, scheduled for late March, the Company intends to discuss proposed modifications to the ongoing pivotal Phase 3 MASTERS-2 clinical trial, which is under special protocol assessment, or SPA, agreement.
|
DCTH | Hot Stocks08:51 EST Delcath Systems makes new drug application resubmission for Hepzato Kit - Delcath Systems submitted a new drug application - NDA - resubmission to the FDA for the HEPZATO Kit seeking approval for the treatment of patients with unresectable hepatic-dominant metastatic ocular melanoma. The resubmission is in response to a September 12, 2013 Complete Response Letter from the FDA. The NDA resubmission contains comprehensive data and information to address all issues identified in the CRL. The FDA is expected to determine whether the resubmission constitutes a complete response and is eligible for review within 30 days. Once accepted for review by the FDA, a new PDUFA action date will be established for the HEPZATO Kit application.
|
MAR | Hot Stocks08:50 EST Marriott CFO: Hiring challenges have moderated
|
CYTO | Hot Stocks08:50 EST Altamira Therapeutics to report Bentrio clinical data at AAAAI Meeting - Altamira Therapeutics announced that data from three clinical studies with the Company's Bentrio nasal spray in allergic rhinitis will be presented February 25, at the Annual Meeting of the American Academy of Allergy, Asthma & Immunology in San Antonio, TX. Poster No. 337: Efficacy and Tolerability of the Barrier-Forming Drug-Free Nasal Spray AM-301 in Allergic Rhinitis Patients Exposed to Controlled Grass Pollen and House Dust Mite Challenge. The presentation will include data from the following clinical evaluations: House dust mite allergic rhinitis. The randomized cross-over study in 37 patients undergoing controlled allergen exposure for 3 hours showed a statistically significant reduction in the change of the Total Nasal Symptom Score with application of Bentrio compared to no protection. The study was conducted by Cliantha Research, Canada. Grass pollen allergic rhinitis. The randomized cross-over study in 36 patients undergoing controlled allergen exposure for 4 hours showed: non-inferiority with regard to the change in the TNSS for Bentrio compared to a hydroxypropyl methylcellulose nasal spray, faster onset of protection, and better subjective ratings of efficacy. The study was conducted by the Fraunhofer Institute for Toxicology and Experimental Medicine, Germany. Nasal residence time. The randomized study in 8 healthy volunteers showed wide distribution of fluorescence-labelled Bentrio for 3.5 hours within relevant parts of the nasal cavity compared to smaller coverage and presence for only one hour with labelled saline nasal spray. The study was conducted by the University of Tubingen, Germany. All three studies of Bentrio nasal spray demonstrated good safety and tolerability.
|
CNDT | Hot Stocks08:48 EST Conduent selected by NMHSD to deliver Medicaid Management Information System - Conduent announced that it has been selected by the New Mexico Human Services Department, NMHSD, to deliver a new Medicaid Management Information System, MMIS, to replace the agency's existing system. Conduent's Medicaid Suite, CMdS, a modular, cloud-based technology platform, will create a seamless experience for providers and improve access for approximately one million state Medicaid members. Conduent will manage the system implementation, and provide maintenance and enhancements designed to reduce costs while optimizing the state's Medicaid operations. "Conduent has proudly served the state of New Mexico for the last 29 years. We are pleased to continue our successful collaboration, now focusing on the transformation of the state's MMIS technology infrastructure. Our commitment is to bring best-in-class solutions and services that help the Human Services Department meet the mandates to reduce program costs and improve the lives of all New Mexicans," said Mark King, President of Conduent Government Solutions.
|
MAR | Hot Stocks08:47 EST Marriott expects loyalty to be modestly cash positive for 2023
|
WAVS | Hot Stocks08:46 EST Cycurion appoints L. Kevin Kelly as CEO - Cycurion announced that L. Kevin Kelly will succeed Emmit McHenry as CEO effective February 14, 2023. Mr. McHenry will continue to serve as Chairman of the Board, focusing his expertise and deep industry knowledge on Cycurion's strategic growth plan. The leadership transition further strengthens Cycurion's senior team as it prepares to become a public company via merger with Western Acquisition Ventures Corp. Kelly began his pivotal role in leadership as CEO of Heidrick & Struggles International where he established the company as a global consulting firm operating in 60 countries. After his tenure at Heidrick & Struggles, Mr. Kelly held several leadership and advisor roles, including as CEO and President of Asia Pulp & Paper and Executive Advisor at BTS.
|
KRKR BIDU | Hot Stocks08:45 EST 36Kr Holdings to integrate Baidu's ERNIE bot - 36Kr Holdings (KRKR) has become one of the first-batch partners of Baidu's (BIDU) ChatGPT-style ERNIE Bot ecosystem. 36Kr will integrate the abilities provided by Baidu's ERNIE AI chatbot, elevating its explorations in applying ChatGPT and AIGC technologies in areas spanning content creation, user interaction, and enterprise service review. Being the first-tier partner, 36Kr will take preliminary steps to internally test the application of ERNIE Bot and integrate its technology capabilities while deepening its collaboration with Baidu on product research and development, as well as standard design.
|
ONDS | Hot Stocks08:44 EST Ondas appoints Reese Mozer as president - The Company announced that Reese Mozer, founder & CEO of American Robotics, has been appointed President of Ondas. Derek Reisfield who has served as Ondas' President will remain CFO, Treasurer and Secretary of Ondas. In addition, Vijay Somandepalli, founder & CTO of American Robotics, has been named VP, Technical Strategy at Ondas.
|
ONDS | Hot Stocks08:43 EST Ondas forms Ondas Autonomous Systems business - The Company announced the formation of Ondas Autonomous Systems, a new business unit to manage the combined drone operations of wholly owned subsidiaries American Robotics and Airobotics. Meir Kliner, Airobotics founder & CEO will assume the role of CEO of the Ondas Autonomous Systems and manage the day-to-day business unit operations.
|
MIRM | Hot Stocks08:42 EST Mirum submits sNDA for Livmarli to treat cholestatic pruritus patients - Mirum Pharmaceuticals announced that it has submitted a supplemental New Drug Application, sNDA for LIVMARLI or maralixibat. oral solution for the treatment of cholestatic pruritus in patients two months of age and older with progressive familial intrahepatic cholestasis, PFIC... LIVMARLI is currently approved in the U.S. and Israel for the treatment of cholestatic pruritus in patients with Alagille syndrome, ALGS, one year of age and older, as well as in the European Union in the same indication, in patients two months of age and older. "Following the groundbreaking MARCH clinical data, we are thrilled at the opportunity to provide the PFIC community in the U.S. a treatment option that significantly reduces pruritus and gives hope for a life less burdened by PFIC," said Chris Peetz, president and chief executive officer at Mirum. "The MARCH PFIC study greatly advanced the understanding of treatment options for PFIC by including the broadest range of genetic types ever studied. We are working urgently to bring LIVMARLI to PFIC patients."
|
ASTE | Hot Stocks08:42 EST Astec to bring OneASTEC product offering to CONEXPO - Astec Industries is returning to CONEXPO-CON/AGG, March 14-18, in Las Vegas, with its comprehensive product offering. Astec will showcase its strength in the infrastructure market and its position to offer customers a one-stop shop of equipment for the asphalt, concrete, mining, quarrying, forestry, and industrial heating industries. "We're excited to feature a variety of new and existing products that have established Astec as a global leader in equipment used to build the infrastructure that connects the world," said Jaco van der Merwe, President and CEO of Astec Industries. "It's also the perfect time to introduce our Astec digital product suite, a completely new technology solution for managing and optimizing our customers' Rock to Road operations."
|
MAR | Hot Stocks08:42 EST Marriott has not seen signs of demand softening, says CEO
|
MAR | Hot Stocks08:42 EST Marriott CEO: Lodging 'not immune' to downturns in economy
|
ASST | Hot Stocks08:41 EST Asset Entities targets Discord's user platform with launch of AE.360.DDM - Asset Entities announced the launch of an online marketing campaign for its suite of services for the Design, Development and Management, DDM, of Discord community servers, AE.360.DDM. AE.360.DDM builds upon the company's digital marketing and content delivery services that it provides to businesses and celebrities across Discord and other social media platforms. The launch of the new marketing campaign for AE.360.DDM follows the development and pilot deployment of AE.360.DDM for a select group of customers last year.
|
SVT | Hot Stocks08:41 EST Star Equity Fund nominates six candidates for Servotronics board - Star Equity Fund, which owns 5.4% of the common stock of Servotronics, announced the nomination of six candidates for election to the Company's board of directors at the Company's 2023 annual meeting of shareholders. The Fund said, "Servotronics shareholders have long endured value destruction and poor corporate governance under the stewardship of the incumbent Board. Although some change to the Board's composition occurred last year, disappointingly, the Company's corporate governance has worsened, its operating and financial performance has failed to improve, and the incumbents have refused to genuinely engage with us despite our substantial shareholding in SVT. Therefore, we have reluctantly concluded the only way to improve shareholder rights and value at SVT is to substantially change the composition of the Board. Put simply, it is a bridge too far for the long-suffering SVT shareholders to believe SVT's financial performance and corporate governance will improve under the incumbent SVT directors, which is why we have nominated six highly qualified candidates for election to the Board. Our nominees are experienced, capable, and fully committed to act in the best interests of all SVT shareholders, and we are fully prepared to make our case for these nominees at the Annual Meeting. In addition, our nominees, once elected, will propose expanding the Board by one seat and having this seat filled by a nomination from the independent shareholders..Star Equity Fund remains resolute in its opinion that significant change in Board composition is vital to altering corporate governance practices, improving financial results, and ultimately unlocking shareholder value at SVT. We believe long-suffering SVT shareholders deserve better, and we aim to give shareholders an opportunity to vote for much-needed change on the Board at the Annual Meeting."
|
MAR | Hot Stocks08:40 EST Marriott sees gross rooms growth about 5.5% in 2023 - Comments taken from Q4 earnings conference call.
|
OSS NVDA | Hot Stocks08:39 EST One Stop Systems receives $1.3M order from U.S. Army to develop vehicle systems - One Stop Systems (OSS) has received a $1.3M order from the U.S. Army for the design, development and prototypes for a ruggedized compute visualization system using OSS PCIe Gen 4 switched fabric technology and NVIDIA (NVDA) Jetson AGX Orin system-on-modules, SoMs. OSS will design and build this system to support 360-degree visualization for U.S. Army ground vehicles. There are more than 14,000 different Army vehicles, many with large blind spots, that may utilize this technology, including the Stryker, Abrams and Bradley. This technology is expected to make vehicles more effective in times of crisis and save service member lives. "The U.S. Army chose OSS for its years of experience ruggedizing compute accelerators and powering them with the latest generation of PCIe technology and embedded GPU processors," stated David Raun, CEO of OSS. "Our superior high-speed PCIe Switch technology provides unmatched low latency compared to traditional fabric connections, with such speed being paramount for mission-critical government applications." The company will work closely with the Army to deliver prototypes later this year.
|
TLS | Hot Stocks08:38 EST Telos receives $32.5M U.S. Air Force contract for DCO - Telos Corporation announced it has been awarded a $32.5M contract to provide Mission Defense Teams, MDT, support for the U.S. Air Force's Air Combat Command, ACC, Defensive Cyber Operations, DCO, weapons systems and mission areas. The DCO WhiteSpace program provides contractor support to perform aspects of plans and programs support, client systems, cyber transport, and cyber operations to augment base personnel in the performance of core information technology services. "The Air Combat Command continues to lead the way in the arena of cyber defense, and Telos is proud to contribute to this effort through improvements to the Air Force's IT systems and mission performance," said John Wood, CEO and chairman, Telos. "As a critical component of this front-line defense capability, Telos is pleased to continue our long-time support of the United States Air Force and the Air Combat Command." This bridge contract represents a two-year extension of a pre-existing program. The contract will be performed across multiple U.S. locations and is expected to be completed in January 2025.
|
LPLA | Hot Stocks08:38 EST LPL Financial reports total advisory, brokerage assets $1.16T at end of January - LPL Financial released its monthly activity report for January 2023. Total advisory and brokerage assets at the end of January were $1.16 trillion, an increase of $54.1 billion, or 4.9%, compared to the end of December 2022. Total net new assets for January were $8.6 billion, which included $3.2 billion of acquired net new assets resulting from the acquisition of Boenning & Scattergood on January 31. Total organic net new assets for January were $5.4 billion, translating to a 5.8% annualized growth rate. Total organic net new advisory assets were $3.1 billion, translating to a 6.4% annualized growth rate. Total client cash balances at the end of January were $59.7 billion, a decrease of $4.4 billion compared to the end of December 2022. Net buying in January was $11.1 billion, a new monthly high.
|
IDR WWR | Hot Stocks08:36 EST Idaho Strategic withdraws proposal to acquire Westwater Resources - Idaho Strategic Resources (IDR) announced that it has withdrawn its business combination proposal to acquire Westwater Resources (WWR) for $1.36 per share due to the Board of Directors of Westwater's continued unwillingness to constructively engage in discussions around a potential combination. The proposal to build a new domestic critical minerals company represented a share price premium of approximately 73% to the last unaffected trading day for both companies prior to the business combination proposal announcement on December 22. "We are disappointed that the Westwater Board has refused to even discuss the potential combination of our two companies and ignored our proposal that would deliver immediate and long-term value to all Westwater shareholders," said John Swallow, Idaho Strategic President and CEO. "Instead of engaging in constructive dialogue, the Westwater Board let this unique and value-generative opportunity to potentially create a company with a clean share structure, a low float, high insider ownership, a significant cash position and several tier 1 critical minerals projects within the United States go unexplored." Swallow continued, "After careful assessment with our advisors, we determined that given the lack of meaningful engagement from Westwater, Idaho Strategic's best path forward at this time is to execute on our own 'production-based' strategy while delivering long-term value for our stakeholders. Our gold operations are hitting stride and the dynamic nature of the REE industry seems to be changing almost daily. With our positioning in the REE industry and actual mining and development experience, our ability to drive results even through periods of increased inflation and global uncertainty, in addition to providing exposure to a decarbonized future is relevant now more than ever. We will continue our disciplined approach to M&A, while monitoring the situation at WWR, and explore value enhancing opportunities just as our shareholders have come to expect."
|
GDNSF | Hot Stocks08:36 EST Goodness Growth appoints Josh Rosen as interim CEO, reorganizes management - Goodness Growth announced the reorganization of several executive roles and responsibilities, each of which are effective immediately. These changes result in a more decentralized organizational structure which gives state-level operating teams greater flexibility to implement market-specific strategies in order to drive improved operations and financial performance. The Company announced that Josh Rosen has been promoted to the role of CEO on an interim basis. Company founder, Dr. Kyle Kingsley, will assume the role of Executive Chairman. Chief Administrative Officer Amber Shimpa has been promoted to the role of President of the Company and CEO of subsidiary Vireo Health of Minnesota.
|
SGBX | Hot Stocks08:36 EST Safe & Green to deliver four medical modules to The Peoples Health Care - Safe & Green announced that the company has entered into an agreement with The Peoples Health Care, a non-profit organization, based in Glendale, California, working in conjunction with Teamsters Local 848, to deliver on or before the end of the second quarter four full mobile medical modules consisting of one Testing Module, one CLIA Lab Facility Module and two Primary Care Modules to locations to be designated by the parties. Each of the medical modules will be ADA compliant and fully designed and equipped with the necessary equipment for a turnkey operation to provide medical services consistent with industry standards. The company is engaged in negotiations with Transcend Health to serve as the clinical operator and staffer of the medical modules providing union members with general wellness, point-of-care medicine, and primary care. Amenities are expected to include, but are not limited to, general wellness, vaccines and testing, specialist referrals, urgent care, imaging and pathological diagnostics, and pharmacy services.
|
CLIR | Hot Stocks08:35 EST ClearSign announces first boiler burner sale - ClearSign announced the first sale of their fire tube boiler burner technology into the California market. The boiler burner order was sold in conjunction with partner California Boiler into the San Joaquin Valley Air Pollution Control District of California. The burner is scheduled to be installed in Q2.
|
ALBO | Hot Stocks08:35 EST Albireo Pharma announces the FDA accepted sNDA, issued PDUFA for Bylvay - Albireo Pharma announced that the U.S. Food and Drug Administration, FDA, has accepted the Company's supplemental New Drug Application, sNDA, and issued a Prescription Drug User Fee Act, PDUFA, action date of June 15, 2023 for a second Bylvay indication for patients with Alagille syndrome, ALGS. With completed submissions for Bylvay in the U.S. and EU for use in patients with ALGS, the Company anticipates approvals in mid-2023. "After completing the regulatory submissions in record time and now with FDA Priority Review acceptance, we are one step closer to bringing Bylvay to market to treat patients with Alagille syndrome, providing hope for this rare disease community that deserves treatment options," said Ron Cooper, President and Chief Executive Officer of Albireo. "With the Phase 3 randomized, placebo-controlled ASSERT data and Orphan Designation, we are planning for approval in Alagille syndrome in mid-2023, expanding access to Bylvay for more of the cholestatic liver community."
|
INCR | Hot Stocks08:34 EST InterCure files suit against Cann Pharmaceuticals following failed merger - InterCure announced today that it has filed a lawsuit against Cann Pharmaceuticals, a company with which it had previously sought to merge, to recover funds loaned and invested in the course of their dealings in connection with the merger agreement.The Company had previously disclosed the merger with Better and its failure in prior press releases made on February 13, 2022, November 23, 2022, and February 1, 2023. The Company and Better had initially agreed to merge, subject to certain closing conditions, which also included an outside date of January 31, 2023. However, as previously disclosed in the Company's public filings, fundamental disagreements arose, which ultimately led to the termination of the agreement on the outside date, as the closing conditions had not been satisfied prior thereto. During the negotiations and after the merger agreement was executed, the Company extended loans to Better, and also provided funding and cultivation services to it, in light of the parties' cooperation. As previously reported, the merger agreement was terminated, leaving the Company to seek to recover the funds it had loaned and extended to Better. Despite repeated efforts to recover such loans, funding and cultivation services, Better has refused to repay the Company, leaving it with no choice but to file a lawsuit against Better to enforce its rights to the amounts loaned to Better.
|
IMAX | Hot Stocks08:33 EST Imax expands partnership in Indonesia for ten new theaters - Imax and Cinema XXI are expanding their longstanding partnership with an agreement for ten new Imax with Laser systems across Indonesia. The new deal will double the size of Imax and Cinema XXI footprint, taking the overall number of Imax commercial systems in Indonesia from ten to twenty. The rollout of the theatres will continue into 2027. Cinema XXI is the largest exhibitor in Indonesia and currently operates nine Imax locations with one additional location in backlog prior to the agreement announced today. The ten new Cinema XXI locations will be equipped with Imax with Laser.
|
IMAX | Hot Stocks08:33 EST Imax expands partnership in Indonesia for ten new theaters - Imax and Cinema XXI are expanding their longstanding partnership with an agreement for ten new Imax with Laser systems across Indonesia. The new deal will double the size of Imax and Cinema XXI footprint, taking the overall number of Imax commercial systems in Indonesia from ten to twenty. The rollout of the theatres will continue into 2027. Cinema XXI is the largest exhibitor in Indonesia and currently operates nine Imax locations with one additional location in backlog prior to the agreement announced today. The ten new Cinema XXI locations will be equipped with Imax with Laser.
|
DDD | Hot Stocks08:33 EST 3D Systems announces availability of ProJet-MJP 2500W Plus - 3D Systems announced the availability of the ProJet MJP 2500W Plus. This new solution is specifically designed to produce complex, high-quality, pure wax 3D-printed jewelry patterns with unparalleled speed and precision for use in the lost wax casting process. Engineered specifically to meet the unique requirements of the jewelry industry, the ProJet MJP 2500W Plus can produce high-resolution 100% wax casting patterns in hours. Additionally, the new high-resolution printing mode enables best-in-class smooth pure wax casting patterns that require less finishing to reduce precious metal waste. This enables the quick and cost-effective creation, iteration, and production of all jewelry styles, including the most complex geometries.
|
JBLU SABR | Hot Stocks08:32 EST JetBlue signs renewed Passenger Service System, distribution agreement with Sabre - Sabre (SABR) announced the multi-year renewal of JetBlue's (JBLU) SabreSonic PSS agreement. The agreement also extends the carrier's long-term distribution agreement to continue offering its content on the Sabre GDS. Sabre will help JetBlue deliver a more tailored customer experience and capture additional revenue opportunities through its PSS. Through the Sabre GDS travel marketplace, JetBlue will distribute its flights and services to Sabre's extensive global network of travel buyers. This will allow Sabre-connected corporate, leisure and online travel agency subscribers to deliver even more choice and value to their travelers.
|
SVRA | Hot Stocks08:30 EST Savara announces Rob Lutz appointed COO, Wilhoit EVP Global Commercial - Savara announced the appointments of two pharmaceutical industry veterans to its executive leadership team. Rob Lutz has been appointed Chief Operating Officer, effectively immediately. Scott Wilhoit was appointed Executive Vice President, Global Commercial, effective January 9 , and Dave Lowrance was promoted from Chief Financial Officer to Chief Financial and Administrative Officer, effective December 13 .
|
RCRT | Hot Stocks08:29 EST Recruiter.com unveils 'Recruiting with ChatGPT' course - Recruiter.com announced the launch of its latest offering, the course, "Recruiting with ChatGPT." The company said, "This innovative course, offered for $199, empowers talent acquisition professionals with cutting-edge techniques for maximizing the use of artificial intelligence in their recruitment."
|
ENSC | Hot Stocks08:28 EST Ensysce to present overdose protection program at NIH HEAL Meeting - Ensysce Biosciences announced a Poster Presentation will be presented by Geoff Birkett, Chief Commercial Officer of Ensysce, at the Annual NIH HEAL Meeting on February 22, 2023, in Washington, D.C. The HEAL initiative is an effort to improve prevention and treatment strategies for opioid misuse and addiction and to enhance pain management across NIH institutes. The HEAL Annual meeting is designed to bring together researchers, federal officials, people with life experience, and other stakeholders to share research findings, explore trends and shared interests, and ultimately to identify opportunities to advance the goals of the initiative. The meeting will include panels, scientific symposia, discussion groups, networking, and poster sessions for in-person and virtual attendees. Ensysce will present its work on the overdose protection platform, MPAR that has been supported by the HEAL program. The clinical development of PF614-MPAR, the first opioid drug product that has both abuse deterrent properties as well as overdose protection, is a direct result of the efforts of this support. PF614-MPAR, designed to provide optimal pain relief at prescribed doses, has overdose protection built into each capsule.
|
AYTU | Hot Stocks08:26 EST Aytu BioPharma announces delayed filing of Q2 results - Aytu BioPharma announced the delayed filing of its Form 10-Q for its second quarter fiscal year 2023, ended December 31, 2022 to allow for additional assessment and management review time on an accounting matter. The matter is related to the accounting for warrants issued in previous financings and we believe will not affect assets, cash and cash equivalents, revenue, cost of goods sold, operating expenses, loss from operations or adjusted EBITDA. The Company will reschedule its quarterly conference call. The Company intends to file the quarterly report as soon as practicable.
|
WRAP | Hot Stocks08:22 EST Wrap Technologies shares new body-worn camera footage from Texas PD - Wrap Technologies shared new body-worn camera footage from the Alton, Texas Police Department, PD. The footage highlights the effectiveness of the Company's BolaWrap Remote Restraint device in resolving potentially dangerous situations. Wrap CEO TJ Kennedy added, "This situation showcases the capability of the BolaWrap to deliver safe outcomes even in dangerous and dynamic scenarios. The decision made by the Alton Police Officer to utilize the BolaWrap was commendable and resulted in a positive outcome for all parties involved. The video also clearly demonstrates the effectiveness of the BolaWrap in stopping a criminal suspect who was running away at full speed, a critical use case for many high-stress scenarios. We believe BolaWrap can be the smart solution to end many foot chases from continuing."
|
CELZ | Hot Stocks08:21 EST Creative Medical Technology announces follow-up data for StemSpine pilot study - Creative Medical Technology Holdings announced positive three-year follow-up data for the Company's StemSpine pilot study. The three-year data demonstrates continued efficacy of the StemSpine procedure for treating chronic lower back pain without any serious adverse effects reported. StemSpine is a patented procedure that primarily utilizes a patient's own bone marrow aspirate for the treatment of chronic lower back pain. The issued patent also covers the use of allogenic cells for this condition, which provides the Company with additional options for treating millions of potential patients suffering from chronic lower back pain. There were no safety related concerns at up to three years, and the StemSpine procedure resulted in a continued efficacy rate of 87% of patients that participated in the pilot study. No patients required re-dosage or surgical intervention since the last follow-up at two years. "To our knowledge, this pilot is the first demonstration of the clinical efficacy of injecting bone marrow aspirate in areas surrounding the disc, thereby potentially repairing, remodeling and improving the blood supply around the disc and lower back area. We believe StemSpine represents an attractive potential option for millions of Americans who suffer from non-surgical chronic lower back pain," said Timothy Warbington, President and CEO of the Company.
|
ZS | Hot Stocks08:21 EST Zscaler announces intent to acquire Canonic Security - Zscaler announced the intent to acquire Canonic Security, a SaaS application security platform innovator. Canonic's platform is designed to prevent organizations' growing risks of SaaS supply chain attacks. "When I speak with the top global CIOs, they consistently express their challenges with efficiently securing supply chain logistics due to the massive blind spot in SaaS-to-SaaS communications. While protecting SaaS platforms is necessary with CASB and SSPM, enterprises must reduce the supply chain attack surface, detect SaaS-native threats and automate responses," said Jay Chaudhry, CEO, chairman and founder, Zscaler. "The addition of Canonic augments our CASB and SSPM capabilities and further strengthens the growing set of services on the Zscaler Zero Trust Exchange, the world's largest cloud security platform, and provides our customers with unprecedented visibility and security of their SaaS applications. I am pleased to welcome the Canonic team to the Zscaler family as we execute on our vision to advance SaaS security."
|
SPXSF | Hot Stocks08:20 EST Spirax-Sarco announces Basic Steam Boiler Operator Training course - Spirax Sarco announced their latest training event: Basic Steam Boiler Operator Training. This five-day course will be held March 20 - 24, 2023 at Spirax Sarco's state-of-the-art training facility in Blythewood, South Carolina where participants will learn virtually all facets of steam boiler operation, maintenance, and troubleshooting. The exclusively designed training course is for Steam Plant Operations, Steam Plant Maintenance Personnel, Steam Plant Supervisors/Managers, Facility Operations/Maintenance Personnel and anyone associated with energy conversion.
|
DCFC | Hot Stocks08:19 EST Tritium announces OK has purchased more than 300 fast chargers - Tritium DCFC announced that OK a.m.b.a., Denmark's largest fuel retailer, has purchased more than 300 fast chargers for use at fuel stations, on highways, in urban areas and retail sites, and with OK's corporate fleet and fleet customers. This deployment of Tritium fast chargers is part of OK's wider plan to support the expansion of Denmark's public charging infrastructure in both large and small Danish cities, providing the fast charging infrastructure needed to support the Danish government's goal of at least 775,000 electric or plug-in hybrid cars on the country's road network by 2030, in a bid to reduce greenhouse gas emissions by 70%. "In 2022, nearly 40% of cars sold in Denmark were electric or plug-in hybrids, providing evidence of the Danish technology transition and solidifying Denmark's position as a global leader in the transition to sustainable transportation," said Jane Hunter, Tritium CEO. "A growing network of public fast chargers will add further momentum to Denmark's EV uptake, and we're pleased to support OK's e-mobility goals. Our partnership with OK will increase drivers' access to fast chargers in Denmark, enabling a more rapid transition to EVs with all of the environmental benefits they bring."
|
BAC | Hot Stocks08:19 EST Bank of America CEO: Bank's branches remain 'critically important'
|
FLNC | Hot Stocks08:19 EST Fluence Energy announces expansion of Fluence Nispera - Fluence Energy announced that Fluence Nispera has expanded to provide real-time performance monitoring, AI-enabled performance analysis, and optimization of energy storage assets, and is currently operational on five energy storage assets totaling 267 MW / 948 MWh globally. The cloud-based asset performance management software is now available for energy storage and all categories of renewables including solar, wind, and hydro.
|
JOBY | Hot Stocks08:19 EST Joby Aviation announces start of eVTOL aircraft final assembly - Joby Aviation announced it has begun final assembly of what is believed to be the world's first company-conforming electric, vertical take-off and landing, eVTOL, aircraft. The aircraft, which is the first to be produced at Joby's pilot manufacturing facility in Marina, California, has been manufactured in accordance with a released design and built according to a complete implementation of a quality management system, qualifying it as a company-conforming aircraft - an important step on the path to achieving the Federal Aviation Administration (FAA) type certification required to begin commercial passenger operations... "It unlocks the path ahead and allows us to exercise our quality management system in preparation for type certification and a subsequent production certification," he added. "There is an incredible amount of work that goes into getting to this point and I'm very grateful for the energy and commitment of the team behind this achievement."
|
INDP CRIS | Hot Stocks08:17 EST Indaptus Therapeutics names Martell to board of directors - Indaptus Therapeutics (INDP) announces it has named Robert Martell, M.D., Ph.D. to its Board of Directors. Having been in the pharmaceutical industry for more than 20 years, Dr. Martell currently serves as Head of Research and Development, as well as previously serving on the Board of Directors for more than six years at Curis (CRIS).
|
NNOX | Hot Stocks08:17 EST Nano-X.AI connects fo Nuance Precision Imaging Network - NANO-X IMAGINGannounced that its deep-learning medical imaging analytics subsidiary, Nanox.AI, has connected to the Nuance Precision Imaging Network. This secure nationwide cloud platform empowers collaborative care teams with streamlined communications and AI insights from diagnostic imaging within existing workflows to improve healthcare outcomes and costs.
|
CDTX | Hot Stocks08:16 EST Cidara regains compliance with Nasdaq minimum bid price requirement - Cidara Therapeutics announced that it has received formal notice from The Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).
|
CAE | Hot Stocks08:16 EST CAE sees FY23 CapEx about C$250M - Total capital expenditures are expected to be approximately C$250M in fiscal 2023, mainly in support of market-led, organic investments. The company usually sees a higher investment in non-cash working capital accounts in the first half of the fiscal year, and as in previous years, management expects a portion of the non-cash working capital investment to reverse in the second half. The company continues to target a 100% conversion of adjusted net income to free cash flow for the year. Having recently concluded a larger-than-usual inorganic growth investment cycle over the last two years, management is now focused on organic investments in lockstep with customer demand, the integration and ramp up of recent investments, and deleveraging its balance sheet. CAE continues to expect net debt-to-adjusted EBITDA to decrease to a ratio of below three times by the middle of next fiscal year (FY2024), at which time it expects to be in position to consider reinstating capital returns to shareholders. CAE expects its annual effective income tax rate to be approximately 22%.
|
ATNX | Hot Stocks08:14 EST Athenex announces reverse stock split - Athenex announced that it will effect a 1-for-20 reverse stock split of its issued common stock, effective at 12:01 a.m. Eastern Time on February 15, 2023. Beginning tomorrow, February 15, 2023, the Company's common stock will trade on a split-adjusted basis. At the Company's Special Meeting of Stockholders held on November 22, 2022, the Company's stockholders approved a proposal to authorize a reverse stock split of the Company's common stock, at a ratio within the range of 1-for-5 to 1-for-20, as determined by the Company's Board of Directors. The Board of Directors approved a 1-for-20 reverse split ratio, and on February 13, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect the reverse stock split effective as of February 15, 2023. The Company's Board of Directors implemented the reverse stock split with the objective of regaining compliance with the $1.00 minimum bid price requirement of The Nasdaq Global Select Market.
|
NSPR | Hot Stocks08:14 EST InspireMD appoints Shane Gleason as GM, North America - InspireMD announced that it has hired medical device commercial veteran Shane Gleason as General Manager of North America and Vice President of Global Marketing. Shane Gleason joins InspireMD from Surmodics, where he served as Vice President of Sales, Vascular Interventions.
|
SESN | Hot Stocks08:14 EST Sesen Bio boosts special cash dividend to 36c per share, Torok to join board - Sesen Bio and Carisma Therapeutics announced that the companies have reached a voting and support agreement with Bradley L. Radoff and Michael Torok .The Investor Group, which beneficially owns approximately 8.7% of Sesen Bio's outstanding common stock, has committed to vote its shares in support of the pending merger. In connection with the Support Agreement, Sesen Bio and Carisma have further amended the previously amended merger agreement announced on December 29 , which has been unanimously approved by the Boards of Directors of both companies: Increased the one-time special cash dividend expected to be paid to Sesen Bio stockholders to $75M, 36c per share. This represents an increase from the expected special cash dividend of approximately $70M, approximately 34c per share, under the first amendment to the merger agreement, and an increase from the up to $25M special cash dividend under the terms of the original merger agreement.
|
TRVN | Hot Stocks08:14 EST Trevena announces publication of OLINVYK respiratory physiology study - Trevena announced the publication of OLINVYK data in the peer-reviewed journal Anesthesiology. The paper, entitled "Respiratory Effects of Biased Ligand Oliceridine in Older Volunteers: A Pharmacokinetic-Pharmacodynamic Comparison with Morphine" was published in collaboration with researchers at several prestigious institutions, including the Leiden University Medical Center in the Netherlands. The paper summarizes the key findings of the four-arm, double-blind, randomized crossover study of eighteen 56- to 87-year-old male and female participants. The intent of the study was to evaluate the difference between oliceridine and IV morphine as measured by the effect on ventilation. The results of the study demonstrated that oliceridine and morphine differed in their pharmacodynamics with a more rapid onset and offset of respiratory depression for oliceridine and a smaller magnitude of respiratory depression over time. The total number of adverse events was similar between the two opioids. The most frequently reported adverse events for oliceridine were dizziness, lightheadedness, somnolence and horizontal vertigo; for morphine, the most frequently reported adverse events were nausea, lightheadedness, dizziness and somnolence.
|
BAC | Hot Stocks08:14 EST Bank of America CEO: Consumer spending activity up in January vs. 2021 - CEO Brian Moynihan, at the bank's Securities Financial Services Conference, said the firm's analysts are predicting a less severe recession on the horizon. He said consumers still have the capacity to borrow.
|
AEY | Hot Stocks08:13 EST ADDvantage appoints Jerry Jones as president, wireless services - ADDvantage Technologies Group announced that it has named Jerry Jones as president of its Wireless Services business unit, effective February 13, 2023. Jones served as Executive Vice President, Customer Unit at Nexius Solutions, where he was responsible for all customer management, business development, deployment and profit and loss nationwide for all customers.
|
MGNI | Hot Stocks08:12 EST TMB leverages Magnite SSP, SpringServe Ad Server - Magnite announced TMB, Trusted Media Brands, has selected Magnite's Demand Manager as its pre-bid wrapper solution. TMB leverages Magnite as one of its preferred omnichannel sell-side platforms, SSPs. SpringServe, now part of Magnite, will serve as TMB's ad server of record for OTT video content. TMB's portfolio of brands reaches more than 200 million consumers worldwide across every screen. "Our teams and technology support media owners across any and every screen and format and TMB is a great example of a content owner that can tap into the full extent of our offerings due to their scale," said Mike Laband, Senior Vice President of Programmatic Platforms at Magnite. "As TMB continues to increase their content offerings across streaming video, display and mobile, we're eager to help them simplify workflows and unlock opportunities through programmatic."
|
ECL | Hot Stocks08:11 EST Ecolab expects double-digit growth in adjusted operating income - The company said, "Ecolab expects to deliver performance that improves throughout 2023 despite a challenging macro environment characterized by high delivered product costs and easing demand. In addition, higher interest expense and currency translation are estimated to have a combined $0.30 per share unfavorable impact in 2023, or a 7% headwind to year-over-year earnings growth. The Company expects double-digit growth in adjusted operating income, driven by continued robust sales growth, easing delivered product cost inflation, and improved productivity. This strong performance is expected to more than overcome the challenging environment to deliver quarterly adjusted earnings per share growth that accelerates towards our low double-digit historical performance."
|
BEEM | Hot Stocks08:11 EST Beam Global receives multiple orders from correctional facilities - Beam Globa announced several orders for EV ARC off-grid EV charging systems were placed by correctional facilities on the east and west coasts of the U.S. The systems were purchased through the California Department of General Services contract #1-22-61-16, which allows state, local and municipal government entities in California and other U.S. states, to purchase Beam products at the California negotiated price, without having to go through a lengthy procurement or technology review process.
|
UNVR | Hot Stocks08:10 EST Univar signs new Ibuprofen distribution agreement with SI Group in Brazil - Univar subsidiary Univar Solutions Brasil announced a distribution agreement with SI Group for Ibuprofen, an active pharmaceutical ingredient used to produce ibuprofen drugs for the pharmaceutical market. Combined with a team of industry experts, a global network of pharmaceutical compliant facilities, and Solution Centers staffed by technical experts, Univar Solutions offers pharmaceutical and biopharmaceutical customers and suppliers support for their pharmaceutical, ophthalmic, nutraceutical, biopharma, animal health and medical device applications.
|
OTLK | Hot Stocks08:10 EST Outlook Therapeutics announces anticipated milestones - Upcoming Anticipated Milestones: Continued progress with ongoing pre-launch commercial preparations in anticipation of potential approval for ONS-5010 in 2023; PDUFA goal date of August 29, 2023; Completion of enrollment in the NORSE SEVEN clinical trial assessing the safety of ONS-5010 in a pre-filled syringe; and Estimated decision date from the EMA's CHMP on the Company's submitted MAA in EU for ONS-5010 expected in early 2024.
|
VXRT | Hot Stocks08:09 EST Vaxart doses first subject in Phase 2 trial of bivalent norovirus candidate - Vaxart announced that it has dosed the first subject in the Phase 2 clinical trial of its oral tablet bivalent norovirus candidate. The dose-ranging study is designed to identify a vaccine dose for a potential Phase 3 clinical trial. "Initiating the Phase 2 clinical trial of this candidate is an important achievement toward our goal of developing an oral tablet vaccine that may reduce the significant global health threat that norovirus poses to children and seniors," said Dr. James F. Cummings, MD, Chief Medical Officer at Vaxart. "Results from the Phase 1b clinical trial in healthy adults demonstrate that this candidate stimulates robust IgA antibody secreting cells against the prevalent strains of two norovirus genotypes that cause the majority of norovirus disease. Data from the Phase 2 trial will inform our further clinical development strategy for this promising vaccine candidate targeting a market estimated at more than $10 billion in the United States alone." This Phase 2 clinical trial is expected to enroll approximately 135 healthy adults at three sites in the United States. Vaxart expects to report topline data from the Phase 2 study in mid-2023.
|
OTLK | Hot Stocks08:09 EST Outlook sees cash runway through anticipated FDA approval of ONS-5010 - In December 2022, the Company closed a registered direct equity offering priced at-the-market under Nasdaq rules, resulting in net proceeds of approximately $24.0 million. Additionally, the Company closed on an unsecured convertible promissory note with a face amount of $31.8 million and net proceeds of approximately $30.0 million after original issue discount and after deducting the lender's transaction costs. The net proceeds from these transactions are expected to provide sufficient capital to support operations past the anticipated FDA approval of ONS-5010 in the third calendar quarter of 2023 and into the fourth calendar quarter of 2023. At December 31, 2022, Outlook Therapeutics had cash and cash equivalents of $52.3 million.
|
TWST | Hot Stocks08:09 EST Twist publishes on discovery of alpaca-derived VHH antibodies - Twist Bioscience published on the successful discovery of alpaca-derived VHH antibodies using a disruptive, function-forward in vivo discovery workflow developed by Abveris, also known as Twist Boston, on the Beacon optofluidic platform. The paper, titled "Alpaca Single B Cell Interrogation and Heavy-Chain-Only Antibody Discovery on an Optofluidic Platform," was published in BioRxiv ..Most antibodies contain two variable domains, the heavy and the light chains; however, camelids make antibodies containing just a heavy chain, from which the VHH single domain is derived. The small size of the VHH single domain antibodies allow them to access targets that traditional antibodies cannot, with tight binding affinities and high specificity. In addition, the lack of a paired light chain in VHH single domain antibodies simplifies downstream engineering, accelerating development timelines. In this proof-of-concept study, custom enrichment, culture, detection, and sequencing methods were used to screen single B cells directly from immunized alpacas for target specificity and heavy-chain-only antibody secretion from alpacas immunized with two different targets, either human prostate specific membrane antigen , PSMA or a second blinded target. B cells secreting target-specific heavy-chain-only antibodies were identified, exported, and sequenced...This unique combination of repertoire sequencing and function-forward single B cell screening could be used for antibody optimization by leveraging Twist's library design platform to generate antigen-biased VHH single domain libraries to discover superior variants. In addition, functional validation of these optimized lead candidates could enable downstream development of high quality PSMA-specific VHH single domain antibodies for therapeutic or diagnostic purposes.
|
TGH | Hot Stocks08:07 EST Textainer board raises quarterly dividend 20% to 30c per share - Textainer's board of directors approved and declared a $0.30 per common share cash dividend, payable on March 15, 2023 to holders of record as of March 3, 2023, an increase of $0.05 per common share, or 20%, from the previous quarter.
|
GROV... | Hot Stocks08:05 EST Grove Collaborative continues retail expansion with Amazon, Walmart - Grove Collaborative (GROV) announced the official launch of its home care brand, Grove Co., on Amazon (AMZN), and at select Walmart (WMT) stores nationwide and Walmart.com. The company also announced its plastic-free personal care brand Peach not Plastic and vegan skincare brand Superbloom reached $1M in sales on Amazon. Starting later this month, Grove will begin rolling out an assortment of Grove Co.'s sustainable household essentials on Amazon including the Grove Co. gel hand soaps, dish soaps and multi-purpose cleaner concentrates, with more products being added during the first half of the year. The Grove Co. debut follows the rollout of the company's plastic-free personal care brand, Peach not Plastic, and vegan skincare brand, Superbloom, on Amazon in 2021. An assortment of Grove Co.'s gel and foaming hand soaps have begun rolling out to more than 1,000 Walmart stores and Walmart.com this month. In addition, select Peach not Plastic and Superbloom products will be sold on Walmart.com. The latest retail additions brings the company's retail footprint to more than 5,000 brick-and-mortar stores.
|
CTVA | Hot Stocks08:04 EST Corteva announces commercial launch of Optimum GLY canola - Corteva announced plans for the commercial launch of Optimum GLY canola - an advanced herbicide-tolerant trait technology for canola farmers. In 2023, Optimum GLY canola will be offered for commercial planting in Canada and the United States through Corteva Agriscience seed brands Pioneer and Brevant seeds. In Australia it will be showcased in Pioneer brand demonstration trials in preparation for full launch in 2024. Accelerated ramp-up in a broader set of genetic backgrounds and maturities will take place in the coming years
|
BWA | Hot Stocks08:03 EST BorgWarner names executives for proposed spin-off company, Phinia - BorgWarner announced Brady Ericson will serve as President and CEO, and Chris Gropp will serve as Executive Vice President and CFO of the separate, publicly traded company that will result from completion of the previously announced proposed spin-off of BorgWarner's Fuel Systems and Aftermarket segments. BorgWarner also announced that the intended company name is "Phinia Inc." The proposed spin-off is expected to be completed in late 2023, subject to satisfaction of customary conditions
|
TRP | Hot Stocks07:55 EST TC Energy files 2022 annual disclosure documents - TC Energy Corporation filed with Canadian securities authorities: Audited Consolidated Financial Statements for the year ended Dec. 31, 2022 with related Management's Discussion and Analysis; and The Company's Annual Information Form for the year ended Dec. 31, 2022. In addition, TC Energy filed its Form 40-F for the year ended Dec. 31, 2022 with the United States Securities and Exchange Commission.
|
ARWYF | Hot Stocks07:44 EST ARway signs six new deals for Software Development Kit - ARway Corporation has signed six new deals for its Software Development Kit (SDK), which showcases the increasing demand for this disruptive technology. The deals range in size from $600-$10,000 based on the usage of the platform. The Company is seeing significant and accelerating interest and deal flow from augmented reality agencies, large corporations and brands that are looking to enhance their wayfinding experience. The Company is now signing up new creative agencies weekly at a cost to the agency of $600-$10,000. These creative agencies already work with dozens or even hundreds of customers and brands that want and need this AR wayfinding technology. By subscribing to the ARway platform, the agency can demonstrate the ARway capabilities to their clients and act as a reseller for ARway's solution. ARway wayfinding solutions range from $15,000-$30,000 annually plus .01/sq ft. The Company is currently in negotiations for multiple full service AR wayfinding contracts that have millions of sq ft to map.
|
AMST | Hot Stocks07:44 EST Amesite announces GPT-3 powered functionality to its AI toolkit - Amesite announced an expansion of platform capabilities. Amesite is now delivering features leveraging GPT-3, the engine for ChatGPT, on its learning platform, to complement its existing AI capabilities. Amesite's V5 Customers now have the option to offer learners an AI-assist in explaining challenging concepts and drafting materials. Amesite CEO, Dr. Ann Marie Sastry said, "We continue to believe that AI is the future of effective, scalable online learning, and have demonstrated the importance of the technology with our 99% retention rate for paid experiences. With curated access to databases with over 240M pieces of qualified information, our users receive updates on important developments in their fields in real time. Internally, we are leveraging generative AI to deliver an ever-expanding roster of advanced tools - enabling us to dramatically reduce our expenses as we target higher revenue."
|
PSN | Hot Stocks07:43 EST Parsons' PSOC to address demand for commercial approach to spacecraft operation - Parsons Corporation established the Parsons Space Operations Center, PSOC, to address the demand for a commercial approach to spacecraft operations and ground control, that maximizes affordability while delivering high-quality and responsive solutions. The PSOC serves as an integrated facility that unifies spacecraft operations for multiple government and commercial programs, creating efficiency and the sharing of knowledge, which translates to cost, schedule, and resource optimization. "PSOC is providing operational support to government and commercial systems, with the ability to support classified and unclassified operations with a mixture of on-premises, cloud, and hybrid ground architectures," said Paul Decker, president, Defense and Intelligence sector for Parsons. "We are accessing multiple partners' global commercial antenna networks to support PSOC operations. We're also leveraging Parsons' innovative technologies like OrbitXchange, our established solution that allows automated and resilient global access for government and commercial spacecraft. A fully trained spacecraft operations staff is already working as the sole-source provider for the Defense Advanced Research Projects Agency Blackjack Ground Operations, and recently added the National Oceanic and Atmospheric Administration Polar Operational Environmental Satellites Extended Life contracts for the NOAA POES-15, 18, and 19 spacecraft."
|
IE | Hot Stocks07:43 EST Ivanhoe Electric provides updated MRE for Santa Cruz Copper Project - Ivanhoe Electric Executive Chairman, Robert Friedland and President and CEO Taylor Melvin are pleased to provide an updated Mineral Resource Estimate for the Santa Cruz Copper Project located west of Casa Grande, Arizona. The updated Mineral Resource Estimate now includes the first Mineral Resources declared at the East Ridge Deposit directly adjacent to the Santa Cruz Deposit and at the Texaco Deposit approximately one mile to the northeast. The updated Mineral Resource Estimate utilizes higher cut-off grades than the 0.39% cut-off used in the December 8, 2021 Santa Cruz Project Mineral Resource statement. The higher cut-off grades were used to account for the consistency and thickness of the higher-grade exotic, oxide and enriched copper domains, which support a more selective, lower-impact bulk mining method. The resource at the Santa Cruz Deposit reflects a 0.70% total copper cut-off, while the resources at East Ridge and Texaco reflect a 0.90% and 0.80% total copper cut-off, respectively. Even at these higher cut-off grades, the overall project-wide contained copper in Indicated Mineral Resources increased by 11%. Importantly, project-wide contained copper in Indicated Mineral Resources, excluding primary sulfide mineralization, increased by 86%. Friedland commented: "We are making great strides towards our ambitious goal of constructing a low-carbon footprint, underground copper mine with minimal surface disturbance in Arizona. The maiden resource estimates for the East Ridge and Texaco Deposits were founded on the knowledge gained from our 26.5 km2 proprietary Typhoon 3D induced polarization and resistivity geophysical survey conducted in 2022 and build on the success we have achieved at the Santa Cruz Deposit. Today's announcement is an important milestone that underpins the future development potential of the Santa Cruz Copper Project."
|
EBIX | Hot Stocks07:41 EST Ebix becomes first to launch UPI for foreign nationals visiting India - EbixCash Limited, a subsidiary of Ebix, announced that it has become the first company in India to pioneer, launch and enable Unified Payments Interface, UPI, transactions for foreign nationals visiting India. This new capability will allow a Foreign national visiting India to pay for goods and services in India, using UPI in seconds. As a part of that initiative, EbixCash has become the first financial services entity in the country to enable UPI services for foreign delegates attending the G-20 submit being held in India. EbixCash will be carrying out a pilot launch shortly in Bangalore at the G-20 summit, involving dignitaries from the world's 20 most powerful nations. T C Guruprasad, Managing Director, Payment Solutions Division and EbixCash World Money said. "We are excited to announce the launch of UPI for foreign nationals exchanging currencies across airports in India. This is in line with our commitment to embrace the vision of India's Prime Minister Mr. Narendra Modi to promote digital transactions in India. This would enable passengers to visit our airport counters across India for converting their foreign currency into digital Indian currency, with a UPI interface to pay for goods and services across the country".
|
BDRBF | Hot Stocks07:40 EST Bombardier announces partial redemption of Senior Notes due 2025 - Bombardier announced that it has issued a notice of partial redemption for $500 million principal amount of its outstanding 7.50% Senior Notes due 2025. As set forth in the notice of partial redemption issued today in respect of the Redemption Notes, the redemption date is March 16, 2023, and the redemption price for the 2025 Notes is 100.00% of the principal amount redeemed, plus accrued and unpaid interest. On February 14, 2023, a copy of the notice of redemption with respect to the Redemption Notes was issued to record holders. Payment of the redemption price and surrender of the Redemption Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company on March 16, 2023. The partial redemption described herein is separate from and unrelated to Bombardier's cash tender offer for a portion of the 7.50% Senior Notes due 2025 that was announced on January 17, 2023 and which expired at 11:59 P.M., New York City time, on February 13, 2023.
|
TMDI | Hot Stocks07:39 EST Titan Medical receives notice of non-compliance from Nasdaq - Nasdaq Listing Rule 5605(b)(1) states that the Company's board of directors must consist of a majority independent directors and Listing Rule 5605(c)(2) states that the Company's audit committee must consist of at least three members, all of whom are independent. Following Ms. Heather Knight's resignation, the Company's audit committee consists of only two members who are independent directors as defined in Rule 5605(a)(2). However, in accordance with Listing Rule 5605(c)(4), Nasdaq has provided the Company a cure period in order to regain compliance, being the earlier of the Company's next annual shareholders' meeting or February 7, 2024; or if the next annual shareholders' meeting is held before August 7, 2023, then the Company must evidence compliance no later than August 7, 2023. The Company is also listed on the Toronto Stock Exchange and the notification letter does not affect the Company's compliance status with such listing.
|
TMDI | Hot Stocks07:38 EST Titan Medical lays off certain members of senior leadership team - Titan Medical announced senior leadership changes and the receipt of a notification from the Nasdaq Stock Market LLC Listing Qualifications Department stating that following the resignation of Heather Knight from the Company's board of directors and audit committee, the Company no longer complies with Nasdaq's audit committee requirement set forth in Nasdaq Rule 5605. Senior Leadership Changes: Following the announcement of February 8, 2023, the Company has decided to layoff certain members of the Company's senior leadership team. Each of these individuals remain available to assist the Company as independent consultants. The following changes are effective immediately: Tammy Carrea is no longer VP, Quality and Regulatory Affairs of the Company. Ms. Carrea will continue to assist the Company, as needed, as an independent consultant with quality and regulatory matters, and to assist with the strategic review process; Kristen Galfetti is no longer VP, Investor Relations and Corporate Communications of the Company. Ms. Galfetti will continue to assist the Company, as needed, as an independent consultant with investor relations and corporate communications, and to assist with the strategic review process; Eric Heinz is no longer VP, Market and Corporate Development of the Company. Mr. Heinz will continue to assist the Company, as needed, as an independent consultant with corporate development activities, and to assist with the strategic review process; and Chris Seibert is no longer VP, Upstream Marketing of the Company. Mr. Seibert will continue to assist the Company, as needed, as an independent consultant with clinical and upstream marketing, and to assist with the strategic review process.
|
BFH | Hot Stocks07:38 EST Bread Financial reports loans at January-end $21M vs. $17M last year - Reports net principal losses at January-end $115M vs. $ 64M last year.
|
MICT V | Hot Stocks07:37 EST MICT's Tingo Mobile, Visa launch pan-African strategic partnership - MICT (MICT), through its wholly-owned subsidiary Tingo Mobile, and Visa (V) announced the launch of their pan-African strategic partnership, which aims to improve access to digital payments and financial services, and drive financial inclusion across Africa. The launch of the Tingo Visa card, together with the new TingoPay Super App and the TingoPay business portal, opens significant global opportunities to Tingo's subscribers, allowing secure cashless payments at more than 61 million merchants in over 200 countries through Visa's global network, as well as the ability for business subscribers to more readily and securely accept payments from customers and other third parties. Darren Mercer, Chief Executive Officer of MICT, Inc. commented: "I am delighted with today's launch of our partnership with Visa and the launch of TingoPay, which are hugely significantly events for the Company. Visa is the perfect partner for our pan-Africa roll-out, with their unrivalled reach throughout the continent. In addition to the enhancement of the offering to our core market of agriculture and farming, the launch of our partnership with Visa and our TingoPay super app also expands our B2B offering to SMEs across all business sectors and sees us introduce our first retail consumer offering. This significant expansion is expected to deliver a considerable increase in revenues and make a considerable contribution to our consolidated earnings in 2023 and beyond."
|
SNGX | Hot Stocks07:32 EST Soligenix receives Refusal to File letter from FDA for HyBryte NDA - Soligenix announced that the FDA has provided the company with a Refusal to File letter for its HyBryte - synthetic hypericin - new drug application - NDA - in the treatment of early stage cutaneous T-cell lymphoma, a rare cancer and area of unmet medical need affecting over 25,000 patients in the U.S. Upon preliminary review, the FDA determined that the NDA, submitted on December 14, 2022, was not sufficiently complete to permit substantive review. Soligenix first learned of the RTF decision via this letter and is reviewing its contents to determine the appropriate next steps, which includes, but is not limited to, requesting a Type A meeting with the FDA to clarify and respond to the issues identified in the letter and to seek additional guidance concerning information that the agency would require for a resubmitted NDA to be deemed acceptable to file.
|
MCRB | Hot Stocks07:28 EST Seres SER-109 data for rCDI published, PDUFA action date set for April 26 - Seres Therapeutics announced the publication of data from its Phase 3 ECOSPOR IV trial in JAMA Network Open that reinforce previously published results from the Phase 3 ECOSPOR III study on the investigational microbiome therapeutic SER-109 for the prevention of recurrent C. difficile infection or rCDI . With nearly 156,000 cases in the U.S., rCDI is a leading cause of hospital-acquired infection and places a significant burden on the healthcare system. "We are proud to see these critical supporting data from the ECOSPOR IV study published in a leading medical research journal. These findings extend our previous results and found that repopulating the GI tract with key protective bacteria via oral delivery can meaningfully reduce the risk of a recurrence of CDI, including in first recurrent patients," said Lisa von Moltke, M.D., Chief Medical Officer at Seres and publication co-author. "Recurrent C. difficile infection places a significant burden on patients, providers and the entire healthcare system and we believe that SER-109, if approved, may provide an important new treatment option for this disease." A Biologics License Application BLA for SER-109 has been submitted to the U.S. Food and Drug Administration FDA and was accepted for Priority Review, with a Prescription Drug User Fee Act PDUFA action date set for April 26 .
|
PRTC | Hot Stocks07:22 EST PureTech Health to advance LYT-300 for treatment of anxiety disorders and PPD - PureTech Health announced that it will advance LYT-300 for the potential treatment of anxiety disorders and postpartum depression, or PPD. A placebo-controlled, Phase 2a, proof-of-concept, social anxiety clinical trial in healthy volunteers is expected to begin in the first half of 2023, with results anticipated by the end of 2023. An open-label, Phase 2a, proof-of-concept clinical trial in women with PPD is expected to initiate in the second half of 2023. The placebo-controlled, Phase 2a, proof-of-concept trial will evaluate short-term changes in anxiety-related patient reported outcomes in approximately 50 healthy volunteers. The trial will be conducted using a validated clinical model that simulates social anxiety. The open-label, Phase 2a, proof-of-concept trial will evaluate LYT-300 in a small number of patients with moderate to severe PPD. It is designed to inform dose selection of LYT-300 in this population given the known efficacy of allopregnanolone in this population, and it will evaluate scores on the HAM-D scale as well as other relevant pharmacodynamic markers.
|
VIRT | Hot Stocks07:18 EST RFQ-hub Holdings appoints Colin Pettorsson as CEO - Virtu Financial announced the appointment of Colin Pettorsson as CEO of RFQ-hub. Before joining RFQ-hub as CEO, Pettorsson spent the previous 10 years managing product development for two other well regarded request-for-quote platforms.
|
POET | Hot Stocks07:16 EST Poet Technologies to demonstrate products at OFC 2023 - POET Technologies announced that it will be hosting live demonstrations of its advanced optical engine and light source products at the 2023 Optical Fiber Communication Conference and Exhibition, OFC. "We have several advanced products to demonstrate at OFC 2023 that we expect to attract substantial customer interest," said Raju Kankipati, Senior Vice President and USA GM at POET Technologies. "All of POET's integrated optical engines are based on POET's Optical Interposer with hybrid integration of best of breed components and monolithic integration of passive elements, resulting in an extremely small chiplet architecture enabling the production of 800G, 1.6T and even 3.2T transceivers in standard pluggable form-factors. We will also be demonstrating and showing mechanical samples of our innovative LightBar products, an essential component for AI-ML accelerator GPUs, an emerging but potentially huge market. As one of the optoelectronics industry's premier events, OFC is the perfect place to highlight our newly released products and to continue growing our network of potential partners and customers."
|
WDOFF | Hot Stocks07:15 EST Wesdome Gold Mines announces results from Kiena Deep A zone - Wesdome Gold Mines announces underground exploration drilling results from the Kiena Deep A zone at the Company's 100% owned Kiena Mine Complex in Val d'Or, Quebec. Over the past several years, underground drilling has focussed on testing areas proximal to the Kiena Deep A zones. As part of this exploration focus, early success discovered the Footwall zones in 2021. Subsequently in 2022, exploration confirmed the presence of the South Limb at depth associated with Kiena Deep A zone, suggesting potential to increase the strike length of the high grade A zone. Later in 2022, drilling intersected two new zones in the relative high rock quality hanging wall basalt that returned 2,850 g/t Au over 1.5 metres. Since November, drill results have extended the Kiena Deep A zone 125 m down plunge. The A zone extends continuously from 1,100 m to approximately 2,000 m below surface and remains open at depth. Hole N103-6840W5 and N103-6840W6 confirmed the extension of the North Limb of the fold, with the overall geometry of the fold confirmed by hole 6840W4, the true thickness of the North Limb remains unknown. The down plunge continuity, volume and grade at depth of the South limb will be tested by future drilling as access is provided by the hanging wall ramp. Additionally, the latest drilling results have also continued to better define and expand the Footwall zones. Lenses FWZ_1 to FWZ_4 were intersected by holes N112-6861, N112-6861W1, and N112-6862W2. The results obtained have extended these lenses and also increased confidence in the validity of the geological model. Hole N103-6839W4 intersected and further defined the Hanging Wall Basalt zone reported in the November 16, 2022 press release. More drilling is planned to better define the orientation and the thickness of this zone. Highlights of the recent drilling are listed below: Hole N112-6861: 75.6 g/t Au over 10.0 m core length A zone; Hole N103-6840W5: 23.7 g/t Au over 5.0 m core length North Limb zone; Hole N103-6840W6: 26.8 g/t Au over 4.0 m core length North Limb zone; Hole N112-6861: 33.6 g/t Au over 21.8 m core length Footwall_2 zone; Hole N103-6839W4: 4.1 g/t Au over 22.8 m core length - Hanging Wall Basalt zone. Assays capped at 90.0 g/t Au for A zone and capped at 35.0 g/t Au for the Hanging Wall Basalt zones. True widths are estimated.
|
APGOF | Hot Stocks07:14 EST Apollo Silver reports gold assay results from Calico Silver project - Apollo Silver reports gold assay results from the Calico Silver Project located in San Bernardino County, California. Results reported herein are from the remaining five reverse circulation, RC, drill holes from Phase 2 of the 2022 Drill Program and new surface sample assay results. "These latest gold results from the Burcham area of the Waterloo Property confirm that the Calico Project has a substantial oxide gold mineralized horizon," commented Apollo's President and CEO Tom Peregoodoff. "This horizon which typically forms part of the footwall to our silver mineralization is extensive and remains open. The spatial relationship between this defined gold horizon and the overlying silver resource is consistent with the simple geometry of the overall resource and opens up additional development optionality in the future. The successful delivery of the objectives of the 2022 program, and the pending mineral resource update should confirm Calico is one of the largest undeveloped silver deposits in the U.S. The potential addition of oxide gold to the mineral inventory will only increase the overall investment attractiveness of the Calico Project."
|
SFR | Hot Stocks07:12 EST Appreciate launches operations in West Palm Beach market - Appreciate Holdings announced the Company's expansion into the West Palm Beach, Florida market. Appreciate's entry into the West Palm Beach market signals the continued growth of the Company's management segment. As Florida continues to see tremendous inbound migration, Appreciate has strengthened its presence in the state and now manages single-family rental homes across six markets. "One of our primary goals at Appreciate is to offer a comprehensive solution for those seeking to invest in and manage SFR," said Appreciate President, Kevin Ortner. "Through our latest strategic expansion, we have added another geographic market where we can provide our clients with an end-to-end solution for high-yield returns."
|
DPRO | Hot Stocks07:12 EST Draganfly fulfills delivery of first situational assessment drone for Ukraine - Draganfly announces it has delivered the first of three Situational Assessment Drones to DSNS Emergency Services Department in Kyiv, Ukraine. Draganfly will also complete the delivery of two Situational Assessment Drones to DSNS in other regions of Ukraine to provide situational awareness intel, infrastructure assessments, and aid in search and rescue operations throughout the country. The Situational Assessment Drone is an automated VTOL drone that utilizes RGB & Multi-Spectral imaging solutions to quickly provide the operator with instantly available maps for future use. The drones are lightweight, easy to deploy, and provide multiple flight and data capture options. "Our drones continue to play a significant role in assisting and aiding the people of Ukraine," said Cameron Chell, President and CEO of Draganfly. "Draganfly has been engaged with several organizations to ensure Ukraine is supported with the best available technology. We are excited to get the first of three Situational Assessment Drones to DSNS Emergency Services Ukraine to make an even greater impact in the country."
|
KO | Hot Stocks07:09 EST Coca-Cola says gained value share in NARTD beverages in Q4, FY - For both the quarter and the full year, the company gained value share in total nonalcoholic ready-to-drink beverages, which included share gains in both at-home and away-from-home channels.
|
PPBT | Hot Stocks07:09 EST Purple Biotech announces first patient dosed in Phase 2 trial of CM24 - Purple Biotech announced that the first patient has been dosed in the randomized part of the open label Phase 2 clinical trial evaluating CM24 in the treatment of advanced metastatic pancreatic cancer, PDAC. "We are excited with the progress made in this study as we start its randomized part," said Gil Efron, Chief Executive Officer of Purple Biotech. "Patients with metastatic pancreatic cancer such as those we are enrolling in our ongoing trial have very few therapeutic options, with relatively short duration of survival. If this study is successful, it may open a path for a short time to market."
|
MAIN | Hot Stocks07:08 EST Main Street makes $12.2M follow-on investment in Iron-Main Investments - Main Street recently completed a follow-on investment in an existing portfolio company. Main Street and its co-investor made the follow-on investment in Iron-Main Investments, in continued partnership with the company's other equity investors to support the company's acquisition of a company that specializes in pre-employment background checks and ancillary related services primarily in the industrial and healthcare industries. Main Street's follow-on investment consists of an additional $11.2M of first lien, senior secured term debt and a $1.0M equity investment. With its companies operating since 1984, Iron-Main provides pre-employment background checks and related services to employers in multiple industries throughout the U.S. This follow-on investment represents Main Street's third follow-on investment in the company.
|
KO | Hot Stocks07:07 EST Coca-Cola reports Q4 global unit case volume down 1%, up 5% for FY
|
JNJ SNY | Hot Stocks07:07 EST Johnson & Johnson appoints Dr. John Reed as EVP of Pharmaceuticals, R&D - Johnson & Johnson (JNJ) announced the appointment of John Reed, M.D., Ph.D., to the company's executive committee as Executive Vice President of Pharmaceuticals, R&D. Dr. Reed previously served as Executive Vice President, Global Head of Research and Development for Sanofi (SNY) and "brings more than 35 years of biomedical research leadership to the company," J&J stated. Dr. Reed will join Johnson & Johnson on April 3, assuming responsibility for the company's portfolio from William Hait, M.D., Ph.D., who has served as interim head of Johnson & Johnson's Pharmaceutical R&D organization since August 2022.
|
GOGO | Hot Stocks07:06 EST Gogo promotes Jessica Betjemann to CFO - Gogo promoted Jessica Betjemann to Executive VP and CFO, and Leigh Goldfine as Chief Accounting Officer. Both appointments become effective March 11 following current CFO Barry Rowan's retirement on March 10. Rowan has served as Gogo's CFO for nearly six years. Betjemann previously served as Senior VP of Finance, Chief Accounting Officer and Treasurer since August 2021, after joining the company as VP, Financial Planning and Analysis in August 2016. Prior to joining Gogo in 2016, Betjemann served as VP of Strategic Business Planning at Nokia in 2016 and held several senior leadership roles in strategy and business operations at Alcatel-Lucent from 2007 to 2015. Prior to that, Betjemann held progressive strategy and finance roles at Lucent Technologies and AT&T. Goldfine re-joined Gogo in October 2022 as Vice President, Corporate Controller after serving as Assistant Controller for Intelsat's Commercial Aviation division since April 2021. He transferred to Intelsat following Gogo's Commercial Aviation division sale in 2020.
|
CGEN AZN | Hot Stocks07:06 EST Compugen: Rilvegostomig expected to progress into Phase 3 this year - Compugen (CGEN) reported that rilvegostomig, AstraZeneca's (AZN) bi-specific antibody derived from Compugen's COM902, is expected to progress into Phase 3 this year. AstraZeneca announced plans to initiate a Phase 3 trial for rilvegostomig, a PD-1/TIGIT bi-specific antibody and is also developing an expanded Phase 2 program.
|
MNPR | Hot Stocks07:05 EST Monopar Therapeutics announces camsirubicin clinical program update - Monopar Therapeutics announced the following update on its currently enrolling open-label Phase 1b camsirubicin Maximum Tolerated Dose, MTD, trial in patients with advanced soft tissue sarcoma, ASTS: Monopar has opened enrollment for the fifth dose level cohort, at an increased dose of 650 mg/m2. To date, no drug-related cardiotoxicity has been observed with camsirubicin treatment as evaluated by the industry standard left-ventricular ejection fraction. Only 17% of camsirubicin patients in the trial have experienced low grade hair loss; another 8% have experienced greater than50% hair loss. Only 8% of camsirubicin patients in the trial have experienced low grade mild oral mucositis. This compares favorably to the roughly 35-40% of doxorubicin treated patients in recent ASTS clinical trials that experienced mild-to-severe oral mucositis. Monopar recently welcomed a second clinical trial site with Dr. Lee Cranmer and the Sarcoma Clinic at the Fred Hutchinson Cancer Center/University of Washington in Seattle, WA. "We are thrilled to partner with Monopar in exploring camsirubicin in patients facing ASTS. So far, camsirubicin has demonstrated a favorable safety profile at up to the 520 mg/m2 dose level assessed to date," said Dr. Cranmer. "Further escalation of camsirubicin dosing will allow us to confirm its favorable safety profile and explore preliminary evidence of camsirubicin's clinical activity in advanced sarcoma patients. While only randomized trials will be able to confirm superiority of camsirubicin over doxorubicin, camsirubicin provides hope that we may finally be able to supersede doxorubicin, a drug in use since its approval in 1974, despite its serious drawbacks. Monopar's continuing efforts to improve ASTS therapy also demonstrate their commitment to changing the treatment landscape for ASTS patients, a population with well-recognized and serious unmet need."
|
MAR | Hot Stocks07:05 EST Marriott: Q1 results to benefit from easier comparison to 1Q22 - Marriott said: "Results in the first quarter are expected to benefit significantly from the easier comparison to the 2022 quarter when the emergence of Omicron depressed lodging demand. Roughly halfway through the quarter, global booking trends remain robust. In January, worldwide RevPAR was up 51.6 percent year over year. Given short-term booking windows and a high level of macroeconomic uncertainty, there is less visibility in forecasting the company's financial performance for full year 2023. As a result, the company is providing a broad range of potential full year RevPAR and other key metrics in the following tables. The high end of the range reflects relatively steady global economic conditions throughout 2023, with continued resilience of travel demand across customer segments and markets. The low end of the range reflects a meaningful softening of the global economy beginning in the second quarter with worldwide RevPAR roughly flat compared to 2022 in the second half of the year."
|
TECH | Hot Stocks07:05 EST Bio-Techne, Cell Signaling Technology announce partnership - Bio-Techne and Cell Signaling Technology announced the addition of Simple Western validation to CST antibodies. This will allow researchers in various disciplines an easier way to study important molecular signaling pathways on a trusted and validated platform. Obtaining accurate data efficiently and fast is key to advancing drug discovery and development. This ongoing partnership will allow for an expanded menu of Simple Western validated antibodies for various targets across multiple disciplines
|
MAR | Hot Stocks07:04 EST Marriott reports retirement of President, International Craig Smith - Marriott announced that Craig S. Smith, Group President, International, has announcedhis decision to retire February 24, 2023, after a 35-year career with the company.
|
GRTS | Hot Stocks07:04 EST Gritstone, NCI establish clinical trial agreement to evaluate SLATE-KRAS - Gritstone bio announced that it has entered into a clinical trial agreement with the National Cancer Institute, an institute of the National Institutes of Health, to evaluate an autologous T cell therapy expressing a T cell receptor targeting mutated KRAS in combination with Gritstone's KRAS-directed vaccine candidate, SLATE-KRAS, in a Phase 1 study. The study will be led by Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch at the NCI's Center for Cancer Research Under the terms of the agreement, NCI will identify patients with metastatic cancer that are eligible for adoptive cell transfer based on the presence of a G12V or G12D KRAS mutation. Gritstone will provide the SLATE-KRAS vaccine as requested by NCI for the trial. An "off the shelf" neoantigen vaccine candidate, SLATE-KRAS demonstrated early evidence of efficacy as defined by molecular response in immune checkpoint blockade-resistant/refractory subjects in the Phase 2 portion of an ongoing Phase 1/2 study. Based on the results to date from the Phase 1/2 study, Gritstone has elected to initiate a separate, randomized Phase 2 study evaluating SLATE against a KRASmut-driven tumor type. Gritstone expects to initiate this separate, randomized study in the second half of 2023.
|
USAC | Hot Stocks07:03 EST USA Compression sees 2023 net income $75M-$95M - Sees 2023 adjusted EBITDA $490.0M-$510.0M.
|
MAR | Hot Stocks07:02 EST Marriott reports January worldwide RevPAR up 51.6% y/y
|
TELA | Hot Stocks07:02 EST Tela Bio awarded biosynthetic mesh products agreement with national GPO - TELA Bio announced a three-year dual-source agreement in the biosynthetic category with one of the Nation's group purchasing organizations. The agreement, which runs through January 1, 2026, offers sizable growth opportunity over the contract period and provides their GPO members access to substantial cost savings and clinical differentiation.
|
ROC DTI | Hot Stocks07:01 EST Drilling Tools International to become public in ROC Energy Acquisition pact - Drilling Tools International and ROC Energy Acquisition (ROC) announced a definitive agreement for a business combination that will result in DTI becoming a U.S. publicly listed company. Upon closing of the transaction, the combined company is expected to be listed under the new ticker symbol (DTI). The business combination implies a combined pro forma enterprise value of approximately $319M, which equates to 5.5x projected 2023 adjusted EBITDA of $58M and 7.8x estimated 2022 adjusted EBITDA of $41M. The transaction is expected to provide net cash proceeds of up to approximately $217M, including approximately $209M of cash from ROC's trust account, before the impact of potential redemptions therefrom, and $45M of cash from a common stock PIPE, which is expected to include meaningful participation by Fifth Partners, an affiliate of ROC's sponsor. Hicks Equity Partners and other existing DTI shareholders will reinvest over 95% of their equity holdings into the combined company for maximum cash on balance sheet. DTI's capital structure positions the company to lead the consolidation of the small-cap oilfield services market. The boards of directors of each of DTI and ROC have unanimously approved the transaction. The transaction will require the approval of the stockholders of ROC and is subject to satisfaction or waiver of the conditions stated in the merger agreement and other customary closing conditions, including the receipt of certain regulatory approvals. The transaction is expected to close in the second quarter of 2023.
|
DGX | Hot Stocks07:00 EST Quest Diagnostics to acquire select assets of NYP laboratory services business - Quest Diagnostics and NewYork-Presbyterian, or NYP, announced a strategic agreement designed to broaden access to quality, innovative laboratory services for the providers and patients of NewYork-Presbyterian primarily in New York as well as the Tri-State Area and beyond. Under a definitive agreement, Quest will acquire select assets of the laboratory services business of NewYork-Presbyterian. NewYork-Presbyterian will still own and operate world-renowned hospital labs, including its anatomic pathology services, to continue providing high quality, complex clinical laboratory services with its academic partners. The parties expect to complete the transaction in the second quarter of 2023, pending customary regulatory approvals. Financial details of the transaction were not disclosed.
|
ASXC... | Hot Stocks06:59 EST Asensus Surgical announces multi-year collaboration with Google Cloud - Asensus Surgical (ASXC) announced a multi-year collaboration with Google Cloud (GOOG, GOOGL) to integrate Google Cloud's secure cloud data architecture and machine learning technologies to further expand the capabilities of the Asensus Surgical's Performance-Guided Surgery framework enabled through the Intelligent Surgical Unit.
|
EXC | Hot Stocks06:58 EST Exelon raises quarterly dividend 6.7% to 36c per share - Exelon declared a regular quarterly dividend of 36c per share on Exelon's common stock for Q1. The dividend is payable on Friday, March 10, 2023, to shareholders of record of Exelon as of 5 p.m. Eastern time on Monday, February 27, 2023.
|
IGT | Hot Stocks06:48 EST International Game deploys PlaySports at Treasure Bay Casino, Hotel Biloxi - International Game announced that it has expanded its sports betting footprint in Mississippi with the deployment of IGT's PlaySports technology at Treasure Bay Casino and Hotel in Biloxi. Under the terms of the agreement, Treasure Bay converted its former retail sportsbook platform to the proven IGT PlaySports solution, including on-premise mobile technology, and IGT's PlaySports trading advisory services.
|
DSGX | Hot Stocks06:46 EST Descartes Systems acquires GroundCloud for up-front consideration of $138M - Descartes Systems announced that it has acquired GroundCloud, a cloud-based provider of final-mile carrier solutions and road safety compliance tools. GroundCloud is headquartered in Minneapolis, Minnesota. Descartes acquired GroundCloud for up-front consideration of approximately $138M satisfied with cash on hand, plus potential performance-based consideration. The maximum amount payable under the all-cash performance-based earn-out is $80M, based on the combined business achieving revenue-based targets in each of the first two years post-acquisition. Any earn-out is expected to be paid in fiscal 2025 and fiscal 2026.
|
PDYPY | Hot Stocks06:43 EST Flutter board consulting shareholders on possible additional U.S. listing - Flutter Entertainment stated in a notice to the London Stock Exchange: "The Flutter Board regularly evaluates how best to position the Group to deliver its strategy in the interests of shareholders. One of the matters the Board has been assessing for some time is the Group's listing structure. The capital markets day held in New York on 16 November 2022 highlighted the growing importance of FanDuel to the Group as a whole. This trend is expected to continue, with FanDuel becoming the Group's largest business by revenue and an ever-greater proportion of its overall value. In this context, the Board has reached a preliminary view that an additional US listing of Flutter's ordinary shares will yield a number of long-term strategic and capital market benefits. The Board believes these benefits would include: enhancing the Group's profile in the US; better enabling the recruitment and retention of US talent; giving the Group access to much deeper capital markets, and to new US domestic investors; providing greater overall liquidity in Flutter shares; and the optionality to pursue, as a second step, a primary US listing - one of the criteria for access to important US indices. The Board appreciates that this is an important topic for shareholders and intends to consult extensively before deciding whether to put forward a formal resolution for approval. The Group expects to start this consultation immediately. In the event that there is broad shareholder support for an additional US listing, this would take precedence over any plans to list a small shareholding in FanDuel. The results of the consultation will be announced in due course."
|
KALV | Hot Stocks06:42 EST KalVista provides progress updates on sebetralstat development - KalVista provided multiple clinical trial and regulatory updates for its lead compound sebetralstat, as a potential oral on-demand therapy for HAE attacks. KalVista has enrolled more than 50% of the 114 targeted number of patients in the pivotal phase 3 KONFIDENT clinical trial. The trial will conclude once 84 of the patients enrolled complete the three-attack treatment sequence. As per previous guidance, topline data for the trial remains expected in the second half of 2023. The company recently received additional FDA regulatory guidance for the oral disintegrating tablet formulation of sebetralstat that confirmed the requirements to support a supplemental NDA filing. The guidance from FDA included that no efficacy trials with the ODT formulation will be required prior to filing the supplemental NDA filing. KalVista anticipates that the ODT formulation will follow the expected initial launch formulation in the US and EU, although it may become the initial launch formulation in other geographies. KalVista also recently received guidance from the Japanese regulatory authority on the clinical development pathway to a regulatory submission in that country. KalVista will now be enrolling Japanese patients in both KONFIDENT and KONFIDENT-S to support the filing, and clinical sites for Japanese enrollment have been selected and start up activities are underway.
|
TRP | Hot Stocks06:41 EST TC Energy increases dividend 3.3% to 93c per share
|
VERV | Hot Stocks06:38 EST Verve Therapeutics: VERVE-101 awarded Innovation Passport by UK MHRA - Verve Therapeutics announced that VERVE-101 has been awarded the Innovation Passport for the treatment of heterozygous familial hypercholesterolemia under the Innovative Licensing and Access Pathway by the Medicines and Healthcare products Regulatory Agency, the regulatory body of the United Kingdom. The ILAP aims to accelerate time to market and facilitate patient access to innovative medicines. VERVE-101 is a novel, investigational gene editing medicine designed to be a single-course treatment that permanently turns off the PCSK9 gene in the liver to durably lower disease-driving low-density lipoprotein cholesterol. Innovation Passport is the first step in the ILAP process and is awarded for a medicinal product addressing a condition that is life-threatening or seriously debilitating and where there is a significant patient or public health need.
|
VSTE NETC | Hot Stocks06:36 EST Vast to go public via business combination with Nabors Energy Transition - Vast Solar and Nabors Energy Transition announced a definitive agreement for a business combination that would result in Vast becoming a publicly-listed company on the NYSE under the ticker symbol "VSTE". The companies said, "Founded in Australia in 2009, Vast's proprietary CSP system uses a modular tower design and a unique sodium loop for heat transfer to efficiently capture and store solar heat for conversion into clean and renewable electricity and heat. The Company's system is designed to deliver greater efficiency, simplified permitting, faster construction and more reliable operations when compared to conventional central tower CSP plants." The Business Combination will provide Vast with capital to progress its multi-GW pipeline of projects, including four projects in various stages of development. Subject to certain conditions, affiliates of Nabors and AgCentral Energy each committed up to $15M of capital in a combination of a pre-closing convertible note financing and a private placement of ordinary shares of Vast at closing. The Company is targeting a minimum of $35M of additional capital from other third-party investors. At closing, the balance of NETC's trust account, net of any redemptions and payment of transaction expenses, will be released to Vast. AgCentral Energy and management will roll 100% of their interests in Vast into the combined company, which the Company believes reflects their support for the combination, as well as confidence in the go-forward prospects for the combined company. The implied pro forma equity value of Vast is expected to be between $305M and $586M depending on the level of redemptions. Vast's existing management team will continue to lead the Company following the completion of the transaction. Vast is expected to remain headquartered in Sydney, Australia. The Transaction was unanimously approved by the Boards of Directors of NETC and Vast. Completion of the proposed Transaction is subject to customary closing conditions and is anticipated to occur in the second or third quarters of 2023. Under NETC's amended and restated certificate of incorporation, Nabors Energy Transition Sponsor, may deposit into the NETC's trust account $2,760,000 to extend the date NETC has to consummate its initial business combination by an additional three months, up to two times. Affiliates of NETC Sponsor expect to deposit $2,760,000 into NETC's trust account prior to February 18, 2023 to extend the date by which NETC has to consummate its initial business combination from February 18, 2023 to May 18, 2023.
|
HRI | Hot Stocks06:33 EST Herc Holdings sees 2023 adjusted EBITDA $1.45B-$1.55B - Sees 2023 net rental equipment capital expenditures $1.0B-$1.2B. CEO Silber said, "As a leader in an industry where scale matters, we expect to continue to gain share by capturing an outsized position of the forecasted higher construction spending in 2023 by investing in our fleet, capitalizing on strategic acquisitions and greenfield opportunities, and cross-selling our diversified product portfolio."
|
FMIV | Hot Stocks06:22 EST Forum Merger IV announces extension date for business combination, signs LOI - Forum Merger IV has elected to extend the date by which FMIV has to consummate a business combination from March 22, 2023 up to an additional eight months to November 22, 2023, as permitted under FMIV's amended and restated certificate of incorporation. The company filed a definitive proxy statement in connection with a special meeting of the company's stockholders to be held on March 7, 2023 to consider and vote on, among other proposals, to amend the charter to allow for the extension. Funds in trust will not be used, now or in the future, to pay for any excise tax imposed under the Inflation Reduction Act of 2022. FMIV intends to deposit the lesser of $175,000 or 5c for each public share then outstanding into the trust account at the beginning of each month. The extension will provide FMIV with additional time to complete a business combination. The company also entered into a letter of intent with a target that is non-binding with respect to all its material terms, except with respect to provisions regarding a limited period of exclusivity. The LOI Target is a company in the online gaming industry, providing its customers with a portfolio of digital gaming products and services. Subject to completion of its related audit for 2022, the LOI Target expects adjusted revenue in excess of $300M and adjusted EBITDA margins of approximately 30%. The LOI Target also expects strong free cash flow conversion for FY23 substantially in excess of 2022 levels. The company cannot assure stockholders that it will be able to enter into a definitive business combination agreement with the LOI Target on terms acceptable to the company or the LOI Target prior to the Extended Date. FMIV announced that the redemption deadline is on March 3, 2023, which is two business days prior to the vote at the Special Meeting on March 7, 2023.
|
QSR | Hot Stocks06:12 EST Restaurant Brands appoints Joshua Kobza as CEO - The board of directors of Restaurant Brands has appointed Joshua Kobza as the company's CEO effective March 1 as part of its ongoing succession planning process. Kobza has held increasingly senior roles with the company over the last 11 years. Kobza will undertake his new role reporting to, and working together with, Patrick Doyle, executive chairman of RBI. Jose Cil will remain with the company for one year as an advisor and assist in the transition.
|
HTGC | Hot Stocks06:11 EST Hercules Capital announces new supplemental cash distribution of 32c per share - To be distributed equally over four quarters beginning with an 8c per share distribution for the fourth quarter of 2022. Record date is March 2 with payment date of March 9.
|
HTGC | Hot Stocks06:10 EST Hercules Capital raises quarterly cash distribution to 39c per share - Record date is March 2 with payment date of March 9.
|
PODD | Hot Stocks06:09 EST Insulet acquires assets of Automated Glucose Control for $25M - Insulet announced it has acquired the assets of Automated Glucose Control, a company in Palo Alto, California focused on developing and commercializing best in class automated insulin delivery technology. AGC and Insulet entered into a license agreement and partnership in 2016 based on patents and other intellectual property that AGC had licensed from the Dr. Francis J. Doyle III laboratory at the University of California, Santa Barbara. The two co-founders of AGC, Dr. Jennifer Schneider and Dr. Thomas Peyser, consulted with Insulet with respect to the licensed technology as part of Insulet's development of its Omnipod 5 Automated Insulin Delivery system. Insulet paid $25M for the acquisition of AGC's assets, which include the license from the University of California and other intellectual property.
|
BRDG | Hot Stocks06:06 EST Bridge Investment to acquire business of Newbury Partners for $320.1M - Bridge Investment Group announced it has entered into a definitive agreement to acquire substantially all of the business of Newbury Partners, an investment manager that specializes in acquiring limited partnership interests in private equity funds through secondary transactions. The all-cash transaction is valued at $320.1M. Bridge CEO Jonathan Slager added, "This acquisition is expected to be immediately accretive to Bridge's core earnings metrics. We see significant near- and long-term growth opportunities to further enhance Bridge's fee related earnings." The transaction is expected to close in the first half of 2023 and is subject to customary closing conditions, including regulatory and investor approvals.
|
F | Hot Stocks05:52 EST Ford announces plans to cut 3,800 jobs in Europe - Ford in Europe announced it is taking the next steps in the transformation of its business, responding to rapidly changing market conditions and a growing field of electric vehicle competitors entering the market. The company today outlined actions that will revitalize its business in Europe and will enable Ford to profitably compete with a new line-up of iconic passenger vehicles, while also extending Ford Pro's position as the best-selling brand in the commercial vehicle sector. "We are completely reinventing the Ford brand in Europe. Unapologetically American, outstanding design and connected services that will differentiate Ford and delight our customers in Europe", said Martin Sander, General Manager of Ford Model e in Europe. The plans include the elimination of approximately 3,800 jobs, creating a leaner, more competitive cost structure for Ford in Europe. Ford will now engage in consultation with its social partners across Europe with the intent to achieve the reductions through voluntary separation programs. By 2025, Ford plans to resize its European engineering footprint, resulting in 2,800 fewer jobs. Additionally, a leaner cost structure will be created for Ford's administrative, marketing, sales and distribution functions in Europe, which includes the elimination of approximately 1,000 positions. Reference Link
|
VHNA | Hot Stocks05:25 EST Roadzen to become public through Vahanna Tech Edge Acquisition I merger pact - Roadzen and Vahanna Tech Edge Acquisition I announced that they have entered into a definitive merger agreement. Upon the closing of the transaction, the combined company will operate as Roadzen and expects to be listed on Nasdaq. The transaction reflects a pre-money equity value for Roadzen of approximately $683M. The merger is expected to close during the second quarter, subject to satisfaction of customary closing conditions. Roadzen's CEO Rohan Malhotra will continue to lead the combined company following the closing of the transaction. The transaction implies a pro forma equity value post-closing of approximately $965M. Estimated cash proceeds from the transaction are expected to consist of Vahanna's $204M of cash held in trust and prior to the payment of transaction expenses. The proceeds of the transaction are expected to fund Roadzen's organic growth initiatives and M&A strategy. All of Roadzen's existing shareholders are rolling 100% of their equity into the combined company. Upon the closing of the transaction, and assuming none of Vahanna's public shareholders elect to redeem their shares, existing Roadzen shareholders are expected to own 73.2% of the combined company. Completion of the proposed transaction is subject to customary closing conditions, including the approval of Vahanna's shareholders and the satisfaction of a $50M minimum cash condition. The boards of directors of each of Vahanna and Roadzen have approved the transaction. The transaction will require the approval of the shareholders of both Vahanna and Roadzen, and is subject to other customary closing conditions, including the receipt of certain regulatory approvals. The transaction is expected to close during the second quarter.
|
KD NOK | Hot Stocks05:21 EST Kyndryl Holdings, Nokia announce extension and expansion of computing pact - Kyndryl (KD) and Nokia (NOK) announced a three-year extension and expansion of their global network and edge computing partnership, with a focus on developing and delivering LTE and 5G private wireless services and Industry 4.0 solutions to customers worldwide. Kyndryl and Nokia established their global network and edge computing alliance in February 2022. The partnership has since grown exponentially, with more than 100 active engagements with global enterprises, from advisory or testing, to piloting, to full implementation, across 24 countries. With a shared vision and commitment to help enterprise and mission critical infrastructure customers accelerate their digital transformations with LTE and 5G private wireless networking, 90% of the current engagements are enterprises in the industrial manufacturing sector - including multinational petrochemical, mining and timber and utilities/energy companies.
|
EGY | Hot Stocks05:16 EST Vaalco Energy increases quarterly dividend, provides operational update - Vaalco Energy announced that the company has increased its quarterly cash dividend to 6.25c per share of common stock for the first quarter, which is payable March 31 to stockholders of record at the close of business on March 24. The company also provided an operational update including fourth quarter production, sales and capital spending. The company increased its quarterly cash dividend by 92% from 3.25c per share in 2022; Production during the fourth quarter was approximately 18,175 BOEPD WI, or 14,200 BOEPD NRI. Additionally, production for the full year of 2022 was approximately 12,150 BOEPD WI, or 10,150 BOEPD NRI, an increase of 43% compared to 2021. Capital spending for the fourth quarter was approximately $55M..
|
HUGE | Hot Stocks05:11 EST FSD Pharma launches new alcohol misuse research, development program - FSD Pharma announced the launch of a new research and development program focused on unmet medical needs for alcohol misuse. "Alcohol intoxication is a common presentation in many patients who visit hospital emergency rooms, and I see this during every one of my shifts. These presentations can require substantial time and effort to manage. Anything that could accelerate recovery from alcohol-intoxication would free up valuable health care resources and provide additional treatment options for alcohol use disorders," said FSD Pharma's Expert Advisory Committee Member Dr. Albert Wong, a psychiatrist who works in the emergency department at the Centre for Addiction and Mental Health in Toronto, Canada.
|
LMND | Hot Stocks05:09 EST Lemonade partners with BNP Paribas Cardif to offer renters insurance - BNP Paribas Cardif is partnering with Lemonade to offer renters insurance. This B2C offer allows a client experience with a 100% online policy subscription and claims submission process on any device. Renters can buy an insurance policy online at cardif.fr or lemonade.com/fr and through the Lemonade app. The insurance policy includes standard coverage such as damage to personal belongings within the insured home and personal liability coverage. The insurance also includes special coverages adapted to the French market and locals' needs: Coverage limits can be adjusted according to policyholders' needs, with a single deductible amount chosen by them to ensure maximum transparency and simplicity. Coverage of personal items that have standalone value under EUR 5,000, and the possibility to select extra coverage for high valuable items. Worldwide coverage of property taken outside the home. Add-on coverage against theft or glass breakage available for those who want extra protection. This partnership comes within the framework of BNP Paribas Cardif's strategic plan, which aims to leverage technology in order to enhance the customer experience, aligned with its core mission of making insurance more accessible.
|
CBOE | Hot Stocks05:05 EST Cboe Global Markets announces expansion plans for CEDX into single stock options - Cboe Global Markets announced that Cboe Europe Derivatives, or CEDX, its pan-European equity derivatives exchange, is planning to expand its product suite to include single stock options on leading European companies. These products are expected to be available for trading in November and cleared by Cboe Clear Europe, the pan-European clearing house, subject to the necessary regulatory approvals. CEDX is initially planning to offer equity options on companies from 10 European countries. Options on stocks from additional European countries are expected to be introduced starting from February 2024, subject to regulatory approvals. CEDX's expansion into equity options will make it one of Europe's most comprehensive equity derivatives exchanges, providing exposure to pan-European equities through single name and index derivatives via a single marketplace. In addition to offering market participants significant operational efficiencies through its pan-European approach, CEDX has also brought to Europe a transparent, on-screen market structure - similar to that utilized in the US - to help attract new participants of all types and grow the region's derivatives markets overall.
|